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Vocabulary 
 
Term Explanation 
Agent An external factor that a person comes into contact with that can cause adverse effects. For 
example, bacteria are biological agents and heavy metals are chemical agents; irradiation is a 
physical agent. 
Biofilm Structures that consist of bacteria and metabolites they produce and that allow bacteria to 
attach to surfaces, protect them from physical and chemical stress and provide nutrition 
BMDL Lower confidence limit of the benchmark dose (BMD), which corresponds to a dose that 
increases the risk of adverse effect with a predetermined amount from the base level of the 
population. The percentage of increase is shown as subscript. For example, BMDL01 is a dose 
that increases a certain risk at population level by 1% compared to that part of the population 
whose exposure is lower than this dose.  
Carcinogenic Producing cancer 
CHD Coronary heart disease 
Complication Secondary disease, side effect (of treatment); a new disorder related to earlier disease or 
treatment of disease 
Colony forming unit 
(cfu) 
Unit used to estimate the number of viable cells in a sample 
Contamination Degree of contamination/pollution 
DALY Disability-adjusted life year, unit of the burden of disease. DALYs measure  
the importance of various diseases and risk factors in terms of harm to the population as a 
whole, that is, premature deaths and years of disability due to illness 
Food hazard Chemical substance or physical or biological factor present in food or the state of food that 
may have a harmful health effect 
Genotoxic Substance that alters cells’ genetic material. 
Hard or saturated fats Saturated fats are fatty acids that only have single bonds between carbon atoms; sources 
include meat dishes, cheeses, milk products. 
HDL cholesterol High-density lipoprotein, good cholesterol, carries cholesterol away from the surface of blood 
vessels and thus prevents narrowing of arteries. 
IHD Ischemic heart disease; long-term oxygen deprivation of the heart muscle  
Incidence Occurrence of new disease cases in a certain population and in a certain time period 
kg bw Kilogram per body weight 
LDL cholesterol Low-density lipoprotein, or bad cholesterol, carries cholesterol to surfaces of arteries. High 
levels of LDL cholesterol in blood indicate arteriosclerosis. Hard fats increase it and soft fats 
decrease it. 
Median The middle number of distribution in a sorted list of numbers 
Meta-analysis Combining of studies; study that combines several other previous studies of the same subject 
and method 
Mortality The proportional number of deaths in a population in a certain time period 
Mutagenic Causing mutations, change in genetic material of gametes or somatic cells (cells other than 
gametes); chromosome or gene mutation. 
Neuropathy Dysfunction of peripheral nerves and/or pathological change 
PAF Population attributable fraction; the fraction of people with a certain illness whose illness can 
be attributed to the studied agent 
Prevalence Proportion of (illness) cases in a certain population at a certain time or in a certain time period 
Risk ratio Risk among those exposed to the studied factor divided by the risk among the unexposed  
Risk factor Social, economic or biological factor, behaviour or environment that is associated with or 
increases susceptibility to a particular disease or problem 
Scenario Description of an imaginary situation and subsequent events that make it possible to move 
from the original situation to this situation 
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Term Explanation 
Socio-economic Concerning interaction of social and economic aspects 
Burden of disease The total harm caused by diseases and factors leading to premature death or disability 
TEQ Toxic equivalency quantity, unit used to assess comprehensive effect of mixture of dioxins 
Teratogenic Causing malformation of an embryo 
Trans fats Type of fats that form in industrial processing and in the rumen of ruminants; fatty acids have a 
double bond, yet the bond is in a configuration that causes negative health effects 
Confidence interval Distance between the maximum and minimum values of a variable 
Contaminant  Substance that has not been added to food deliberately but that is prevalent in food due to 
contamination in primary production, manufacturing, processing, preparation, handling, 
packaging, transportation or storing or due to environmental contamination. Foreign 
substances, such as residuals of insects or animal hairs are not included in this definition. 
Vegetables Succulent plants or parts of plants used as food (root vegetables and greens), can also mean 
berries, fruits, mushrooms and cereals 
µg microgram, 1 x 10-6g, one millionth of a gram 
pg picogram, 1 x 10-12g 
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1 Introduction 
1.1 Background 
Food contributes significantly to the health of the population through nutrition and food 
safety in both the European Union (EU) and in Finland (University of Washington 
2019). However, detected and reported foodborne illnesses are only a fraction of the 
actual cases, as the vast majority remain unreported. The consequences of diseases 
are mainly determined by the impact of air pollution, infectious diseases or poor nutri-
tion (malnutrition; excess intake of, for example, saturated fat, salt and sugar; or over-
weight) on human health. The long-term consequences of biological, chemical or 
physical hazards related to food and drinking water have been studied less. 
Nutritional factors have a major impact on the health of Finns. The Western pattern 
diet typically comprises food that is too high in energy, saturated fat, salt and added 
sugar (Nordic Council of Ministers 2014). Excessive energy intake leads to overweight 
and may predispose people to certain cancers. Saturated fat increases the level of 
harmful low-density lipoprotein (LDL) cholesterol in the blood and therefore increases 
the risk of cardiovascular disease. High salt intake is associated with high blood pres-
sure and death due to stroke and coronary heart disease. A diet rich in fruits, berries 
and vegetables protects against cardiovascular disease and is likely to prevent certain 
cancers. Dietary whole grains have been associated with a reduced risk of cardiovas-
cular disease and type 2 diabetes. Fish consumption is linked to lower cardiovascular 
mortality, whereas red and processed meat increase the risk of colon and rectal can-
cers (Nordic Council of Ministers 2014). Nutritional health hazards are usually the re-
sult of a long-term unhealthy diet, and preventing the associated public health risks 
requires a permanent change in Finns’ eating habits. 
The Finnish Food Safety Authority Evira (now the Finnish Food Authority) has identi-
fied nearly 20 foodborne biological hazards (Hallanvuo & Johansson 2010) and about 
30 chemical substances or groups of substances that may have a significant impact 
on the health and well-being of Finns (Hallikainen et al. 2013). Some chemicals are 
carcinogenic, and some are acutely toxic. Most chemical and toxin exposures are as-
sociated with potential effects of chronic long-term exposure, particularly in vulnerable 
populations. In addition to acute food poisoning, biological food hazards can cause 
sequelae. 
Food chain quality management systems and controls aim to limit these risks. Alt-
hough a relatively high level of food hygiene has been achieved in Finland, thousands 
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of foodborne infections occur every year, and food contaminants contribute to the bur-
den of disease (BoD) on consumers (Jaakola et al. 2017). The chronic public health 
effects of risks related to food hazards are not well known and are not described in a 
comparable format for prioritization. The costs of risk management for some parts of 
the food chain have been estimated for Finnish society and companies, but to our 
knowledge there is no overview of the main cost factors. 
Food is by far the most important single determinant of population health. At the EU 
level, food-related factors are estimated to have caused a total loss of 32,700 disabil-
ity-adjusted life years (DALYs)/million population in 2015. In Finland, the correspond-
ing estimate was 31,500 DALYs (University of Washington 2019). These hazards 
arise in the food chain, which is driven by economic, biophysical and socio-political 
mechanisms (Nesheim et al. 2015), the products of which are used by consumers in 
accordance with their personal and cultural priorities, preferences and habits. Some of 
the risks arise from defects in the storage and handling of food in the part of the food 
chain for which the consumer is responsible. The importance of all the above factors 
is accentuated as multiculturalism increases (Harris et al., 2015), and successful influ-
encing in them is a way to reduce the cost of illness. 
This project (Costs and Risk Assessment of the Health Effects of the Food System, 
RUORI) aimed to create a comparable general view of the severity of health hazards 
(individual risk) and their public health significance according to the health hazards 
and their exposure levels defined by Evira and the BoD methods developed by the 
National Institute of Health and Welfare (THL) in Finland. In addition, the project uti-
lized the results of ongoing and completed risk assessments by the Finnish Food Au-
thority. Registry data and international estimates were utilized to provide a true picture 
of the BoD, given that only a minority of mild abdominal symptoms will be diagnosed 
by a physician. The cost-effectiveness of scenarios seeking to reduce the BoD or 
costs was assessed. 
Finnish food companies aim to double their exports by 2025. Some completed risk as-
sessments based on scientific evidence have already been used to promote exports 
by demonstrating the high hygiene and low risk level of food raw materials and prod-
ucts (risk assessment projects of the Finnish Food Authority: https://www.ru-
okavirasto.fi/en/organisations/risk-assessment/projects-of-risk-assessment/). Meeting 
the export conditions of important export countries, such as those in the Eurasian 
Economic Union, Russia, China and the United States, in a cost-effective way would 
be particularly important in the future for Finnish companies. Therefore, the export re-
quirements and control conditions were clarified and assessed in this project. 
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1.2 Aims of the project 
The main aims of the project were to: 
1. identify the major food- and nutrition-related health and economic risks 
in Finland and the factors affecting them; 
2. classify the risks and the factors affecting them based on the results and 
thus provide information for risk management; 
3. identify food safety needs in relation to export; 
4. highlight priority areas for food safety research and information gaps; 
5. prepare a current economic cost estimate for the treatment, prevention 
and control of foodborne diseases; and 
6. assess the computational impact of suggested measures, such as de-
regulation. 
1.3 Assessed hazards and factors 
For chemical, biological and physical food hazards and nutritional factors, three to 
four types of hazards from each group were considered as examples. Their selection 
was based on the available information on their effects and costs, although the final 
choice was also influenced by the amount of information available for each hazard. 
Different hazards can be economically significant, either because of the illness they 
cause or the cost of risk management. In addition, factors were chosen to target the 
costs of the various risk management actors (e.g. own-check sampling, official con-
trol) and the hazards with health consequences of varying severity (e.g. acute infec-
tions, long-term sequelae). Efforts were made to review the costs of control through-
out the production process. The economic significance was addressed from several 
perspectives—illness, control costs, industry and food supply. Risk perceptions and 
factors affecting political decision making were also considered to the extent allowed 
by the data. Reported treatment costs for the diseases and epidemics over the period 
2014–2016 were related to the number of disease cases that may have been caused 
by the chosen example food hazards but that were not reported. 
The study also aimed to assess the impact of food law flexibility on food safety and 
the costs of controls and illness. There may be flexibility in the requirements of the 
legislation, such as exemptions and adjustments, but ‘deregulation’ must not endan-
ger food safety or increase morbidity ((EC) 862/2004, 13, 853/2004, 10, 853/2004 Art. 
17). The possibility of reducing trichinella testing in meat inspection was used as an 
example of deregulation. 
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Biological hazards 
Four biological hazards, Listeria monocytogenes, human norovirus, Toxoplasma 
gondii and Trichinella parasitic roundworms, were studied in this project. 
Listeria monocytogenes (hereafter 'Listeria') was included in the assessment be-
cause the disease is diagnosed more frequently in Finland than in other EU countries 
each year. There have been national requirements for managing Listeria, but the cur-
rent microbial criteria in Regulation (EC) No. 2073/2005 sets limits for Listeria in the 
manufacture and end products of several foodstuffs (safety and hygiene criteria). The 
consequences of listeriosis can be extremely severe and even fatal, particularly for 
pregnant women, fetuses, infants, the elderly and those who are immunocompro-
mised, for example, due to chronic illness. 
Norovirus is the most common cause of foodborne epidemics in Finland. There have 
been large seasonal outbreaks and, despite the relatively mild symptoms, significant 
economic costs due to sick leaves. Norovirus gastroenteritis can be dangerous for im-
munocompromised individuals. 
The effect of parasitic toxoplasma was assessed, as toxoplasma is the third most 
significant pathogen in Europe according to the World Health Organization (WHO). 
The symptoms range from mild ones to pneumonia, encephalitis and visual impair-
ment. However, there are no risk management practices to prevent the parasite. 
Cases of Trichinella are very rare in Finland. However, the risk management costs in 
the form of laboratory tests on slaughtered animals are massive. The possibility of re-
ducing the number of analyses has been discussed. The health consequences of 
trichinellosis range from mild to severe and even fatal. 
Physical hazards 
Among the hazards that present physical risks, foreign objects, such as broken 
glass, pieces of metal and wood splinters, and radiation are the most commonly men-
tioned. Foreign objects can mechanically contaminate food and can cause, for exam-
ple, asphyxiation or tooth damage. According to the information gathered in this pro-
ject, companies find the possibility of foreign objects in their products such a severe 
reputational risk that they are not willing to reduce their own-check measures. 
Certain foods can be irradiated with ionizing radiation to improve shelf life. Only a 
narrow range of irradiated foods (spices, hospital food) can be sold in Finland. Food 
irradiated according to the guidelines is not radioactive. Low levels of radioactivity 
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may be observed as a result of deposition, mainly in natural products. Background ra-
diation is often more intense than the measured radiation from deposition. In Finland, 
the Finnish Food Authority supervises the irradiation of foodstuffs, the Customs labor-
atory controls import, and the Radiation and Nuclear Safety Authority monitors radio-
activity levels. Because of the non-existent need for changes in control, the physical 
hazards were not assessed in terms of public health or economic risks in this project. 
Chemical hazards 
The chemical hazards of aflatoxins, dioxins and lead were studied in this project. 
Aflatoxin was selected for evaluation because maximum permissible levels in food-
stuffs have been set in the Contaminants Regulation ((EC) No. 1881/2006 and nation-
ally (MMM 880/2016). Aflatoxin was also one of the chemicals studied in WHO’s BoD 
assessment. Aflatoxin exposure also links to a nutritional aspect, as the consumption 
of nuts is promoted and exposure to aflatoxins may thus increase. The climate may 
also become more favourable for the formation of aflatoxins. The importance of afla-
toxins is further increased because they are monitored in several food categories. Af-
latoxin exposure can have health consequences, as aflatoxins are the most muta-
genic and carcinogenic substances known. 
Dioxins were selected for evaluation because they are monitored in several food 
groups and have high analytical costs. Although preliminary results indicate that the 
levels of dioxins in food have decreased, they may be present in products that are in-
creasingly consumed, such as imported cheeses. Finland has a derogation for the na-
tional sale of certain fish species from the Baltic Sea, although they may exceed the 
limits of EU legislation. Dioxins may cause developmental disorders. 
The inclusion of lead in the evaluation was justified by the fact that maximum levels of 
lead for several food categories have been set. Although exposure to lead via food 
has decreased during Finland's EU membership, the exposure of Finnish 1–3-year-
olds is still worryingly high. Potential health consequences of lead exposure include 
cognitive impairment, hypertension, kidney damage and anaemia. 
Nutritional factors 
The following key points of concern regarding nutrition in Finland were selected for 
the evaluation: the inadequate consumption of fruits and vegetables and the exces-
sive intake of salt and fat. 
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Finns eat too few fruits and vegetables, even though they are known to have many 
health benefits. High consumption of fruits and vegetables prevents cardiovascular 
disease and possibly some cancers. They are high in dietary fibre and protective nu-
trients (Nordic Council of Ministers 2014). Achieving a feeling of satiety with less en-
ergy may help with weight management. According to the European Food Safety Au-
thority (EFSA 2008), it would be possible to prevent some 26,000 cardiac or cerebral 
infarction deaths in people under the age of 65 in the EU by increasing the proportion 
of fruits and vegetables consumed. 
Almost all Finns get more salt than recommended from their diet (Valsta et al. 2018). 
There is much evidence that excessive salt intake causes hypertension. High salt in-
take has also been linked to the risk of stroke, cardiovascular disease, stomach can-
cer and osteoporosis (Nordic Council of Ministers 2014). There has been an attempt 
to reduce salt intake with a regulation requiring that certain foods be labelled with a 
warning that the salt content exceeds the regulatory limit. The salt content of food is 
one of the criteria for products or restaurant items to have the ‘Heart Symbol’, an initi-
ative launched by the Finnish Heart Association to indicate nutritional quality. 
The amount and quality of fat affects the healthiness of one’s diet. More than one 
third of Finns get too much fat from their diets compared to recommendations, and 
most consume more saturated fat than recommended (Valsta et al. 2018). Fat is high 
in energy, and a high-fat diet can increase the risk of being overweight. Saturated fats 
increase the level of harmful LDL cholesterol and are a major risk factor for cardiovas-
cular disease. They may also reduce insulin sensitivity and increase blood pressure. 
Due to the changed production processes in the food industry, the intake of harmful 
trans fatty acids is currently low (Nordic Council of Ministers 2014). The proportion 
and quality of fats are also included in the criteria to acquire the Heart Symbol men-
tioned above.  
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2 Materials and methods 
2.1 Materials 
Data related to food control, primary production, production and retailing are derived 
from the surveys and interviews conducted during the project. 
To support the development of the scenarios as a part of the RUORI project, a work-
shop was held in December 2018. In the workshop, enterprise and supervision ex-
perts provided comments and information that was utilized in preparing and editing 
the scenarios. 
2.1.1 Biological food hazards 
This project assessed the impact of biological food hazards using WHO estimates. 
The BoD assessment for biological factors (Listeria, Norovirus and Toxoplasma) 
based on the WHO report (WHO 2015) used a method based on morbidity (incidence) 
that takes into account the incidence of biological agents, the age and sex of the pa-
tients, duration of disease, life-years lost due to possible death and disease-related 
disability weight. The values used in the WHO report to calculate BoD are based on 
either global estimates or regional data estimates, as appropriate. Biological hazards 
have no national estimate for Finland, but the estimates are based on data from the 
European territory, assuming that Finland is a typical European country in this re-
spect. Norovirus and Listeria estimates have been updated according to the THL in-
fectious disease register. The burden of trichinellosis was estimated to be non-exist-
ent, as no infections have occurred in Finland in the 2010s. 
Underreporting of disease cases has not been investigated in Finland. Underreporting 
is expected to be relatively common in mild illness cases. Tam et al. (2012) estimated 
that about 94% of patients with gastrointestinal infections do not seek treatment. 
Overall, reporting activity for biological agents is estimated to be around 10%–30%, 
meaning that 70%–90% of those infected are not included in the reports. 
2.1.2 Chemical food hazards 
The BoD assessment of aflatoxins relied on the WHO report calculation, which was 
updated with values of Finnish exposure from the EFSA report (EFSA 2018) and from 
Finnish liver cancer registry data, and the assumption that the prevalence of hepatitis 
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B in Finland is 0.5%. The EFSA estimate is based on the national food consumption 
data The Finnish Type 1 Diabetes Prediction and Prevention Study (DIPP) (Kyttälä et 
al. 2008), Findiet 2012 (Helldán et al. 2013) and data on peanut levels collected from 
all EU countries. It does not include other sources of aflatoxins, such as, inter alia, 
tree nuts. 
The lead exposure of Finns has been studied in Finnish Food Authority projects (Finn-
ish Food Authority 2019d). The exposure of adults (Suomi 2019) and children from 1–
6 years of age (Suomi et al. 2015) has been statistically (probabilistically) estimated 
from the national food consumption data DIPP (Kyttälä et al. 2008), Findiet 2012 
(Helldán et al. 2013) and official and own-check samples analysed in Finland. Findiet 
studies represent the food consumption of the Finnish population well, but no such in-
formation exists for children, as DIPP data has been collected only from one area and 
all the studied children had a gene that predispose them to type one diabetes. There-
fore, the study had limited capability to represent Finnish children. The BoD assess-
ment was based on exposure estimates using the THL model. 
Exposure to dioxins was not evaluated, as the BoD was recently estimated in the 
GOHERR project (http://en.opasnet.org/w/Goherr_assessment) using WHO’s assess-
ment, thus updating the calculated dioxin levels in Baltic Sea fish and dl-PCB-related 
disease in Finland. 
2.1.3 Nutritional factors 
Finns’ consumption of fruits and vegetables and intake of salt and saturated fat are 
derived from the National Findiet 2012 and 2017 surveys (Helldán et al. 2013; Valsta 
et al. 2018). Estimates of the BoD related to the underconsumption of fruits and vege-
tables and the excessive intake of salt were strongly based on the global burden of 
disease (GBD) calculations of the Institute for Health Metrics and Evaluation (IHME) 
(University of Washington 2019). For excessive salt intake and underconsumption of 
fruits and vegetables, IHME data were updated according to intake data from the lat-
est Findiet study in 2017 (Valsta et al. 2018). The BoD caused by saturated fat was 
evaluated using the IHME data on cardiovascular and vascular disease cases and the 
amount of fat intake in Findiet studies. Unlike trans fat, the BoD caused by saturated 
fat has not been separated into its own factor in the IHME GBD database. In Finland, 
the recommended dietary fat intake is 25%–40% of the total energy intake, and the 
recommended intake of saturated fat is less than 10% of the total energy intake. 
In the IHME data, the underconsumption of fruits and vegetables was considered sep-
arately, causing the acceptable daily intake to be higher than the Finnish recommen-
dation. The underconsumption of vegetables for IHME data means less than 
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400 g/day (University of Washington 2019b). The underconsumption of fruits means 
less than approximately 310 g/day. The limit for the underconsumption of fruits and 
vegetables (710 g in total) used in IHME data differs from the daily intake of 500 g ac-
cording to Finnish Nutrition Recommendations (VRN 2014). In IHME data, excess salt 
intake refers to the consumption of more than 2.5 g/day, which also differs from the 
recommended daily intake of up to 5 g according to Finnish dietary recommendations. 
IHME GBD (University of Washington in 2019) was used in the RUORI project and 
classifies fresh, frozen, cooked, canned and dried vegetables, including legumes, as 
vegetables, but this does not include canned vegetables preserved with salt or vine-
gar, nuts, seeds and starchy vegetables, such as potatoes and corn. Fruits are classi-
fied as fresh, frozen, cooked, canned and dried, but this does not include fruit juice or 
fruit preserved with salt or vinegar. It was assumed that berries belong to the same 
category as fruits, but this is not apparent from the IHME definitions. 
2.2 Methods 
2.2.1 Surveys 
To find out about current costs, food control units, the Finnish Food Authority’s control 
department and the Customs laboratory were surveyed. Primary production facilities, 
food production facilities and retail stores were surveyed separately. They were asked 
for control or own-check working hours and annual sampling and laboratory costs re-
lated to the food hazards studied in this project. In addition, the costs of complaints of 
food poisoning in 2014–2016, the means used to control food hazards, the proportion 
of non-compliant food samples in the samples examined and the cost of obtaining and 
using the Heart Symbol were examined. The survey for the control authorities ad-
dressed the same issues and contained the same control measures targeted at food 
business operators over the period 2014–2016 based on the factors examined in the 
project. 
The survey was originally formulated as an electronic Webropol survey that was sent 
to the Retail Federation (PTY), the Travel and Restaurant Association (MaRa), the 
Food Industry Association (ETL), Customs, local control units and the Finnish Food 
Authority control units. Due to the low number of responses, the survey, which was 
open in October–December 2018, was re-opened in January–February 2019. The 
survey was supplemented with telephone interviews with the same set of questions as 
the original survey. Eight replies were received from the authority and 35 from primary 
production facilities, food production facilities and retail operators. Due to the low 
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number of responses, the missing information was supplemented with information ob-
tained through data mining. 
The Export section of the Finnish Food Authority was also interviewed regarding the 
importance of chemical, biological and physical food hazards, nutritional factors and 
their control over food exports. 
2.2.2 Assessment of burden of disease 
The BoD is a metric to measure a population’s loss of health. It combines years lived 
with disability (YLD) and years of life lost (YLL) due to attributable mortality. BoD is 
measured in DALYs (Hänninen & Knol 2011). BoD is calculated as follows: 
𝐵𝐵𝐵𝐵𝐵𝐵 = 𝑌𝑌𝑌𝑌𝑌𝑌 + 𝑌𝑌𝑌𝑌𝐵𝐵. (1) 
Nation-level assessments of BoD have been done by IHME (University of Washing-
ton, 2019c) and by the WHO Global Health Estimates (GHE) project in recent years. 
Both constantly update their methods and the data used. From the data used by the 
IHME, it is possible to retrieve national estimates of BoD for diseases and risk factors, 
including nutritional factors. 
Assessing BoD relating to different factors, in this case nutritional ones, can be done 
using a few basic methods. Which method to use depends on the dataset used. Meth-
ods based on epidemiological relative risk (RR) and unit risk (UR) can be seen as pri-
mary methods (Figure 1). These methods can be used to estimate the population at-
tributable fraction (PAF) for an exposure agent. PAF describes the portion of a popu-
lation’s morbidity that can be attributed to a certain exposure factor. PAF combined 
with the total burden of a disease (or if that is lacking with the total incidence rate of 
the disease) gives the BoD attributable to the exposure factor (BoDa). In this project, 
the PAF approach has been used to calculate the BoD of aflatoxins, dioxins and nutri-
tional factors. 
If data required for calculating the PAF are not available, the BoD can be calculated 
from estimates of the disease cases caused by the exposure factor and the estimated 
severity and length of a case of disease. The calculations are based on the following 
equation: 
𝐵𝐵𝐵𝐵𝐵𝐵 = 𝑌𝑌 × 𝐵𝐵𝐷𝐷 × 𝑛𝑛, (2) 
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where L is the length of the disease or, in case of death, the number of life years lost 
to premature death, Dw is the severity of the disease (in case of death 1) and n is the 
number of cases. This method has been used in this project to calculate the BoD 
caused by biological factors. It leans heavily on a WHO report in which the BoD of 
food-related factors was assessed. 
 
Figure 1. The calculation model for burden of disease. The blue boxes represent parts of the model and ar-
rows the data required for calculations. Where possible, the equation used in the part of the model is shown 
next to the box. All exposure factors and health responses were calculated using the same model, but be-
cause of the differing initial data the calculations started from different places in different cases. Relative 
risk was used for exposure factors for which the risk is relative to the prevalence of the disease in a popula-
tion (e.g. factors increasing the risk of heart disease). Unit risk was used in situations where the risk is inde-
pendent of this (e.g. a developmental disorder of teeth caused by a dioxin is not dependent on any other 
developmental disorders or tooth damage). The figure has been modified from Hänninen & Knol, 2011. 
BoD is often reported for a certain year (e.g. calculated with data from 2016) or for 
‘the present’ if the initial data is not all from the same year but approximately corre-
spond to the time the assessment was made, as is the case for this report. In the lat-
ter case, the results are reported as BoD/year (DALY/year) or the BoD caused by one 
year of exposure. However, this phrasing contains some assumptions, so it is im-
portant to take care when interpreting results. 
First, the result does not mean that all harm caused by exposure manifests during the 
same year. For example, liver cancer caused by aflatoxin can manifest decades after 
exposure, and one death from cancer can shorten the patient’s life by multiple years. 
However, in the calculations all harm, including future harm, will be allocated to the 
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year of exposure. Harm occurring far in the future tended to be discounted or as-
sessed as less severe than immediate harm, but this practice has mostly been aban-
doned. This report does not discount health impacts. 
Second, a PAF tends to allocate health impacts to different exposure factors, assum-
ing that it directly tells about the behaviour of the disease. However, it is not possible 
to say, even with very accurate observational data, how the health of the people 
would have progressed if the exposure studied had not occurred. They may have 
fallen ill with some other disease, in which case the health benefit would be smaller 
than estimated and the harm from this other disease bigger than estimated. Epidemio-
logical research also has the limitation that the observed difference in loss of life years 
in populations with different exposures cannot be directly converted into numbers of 
disease cases without additional assumptions. A similar limitation exists for impact as-
sessments. In this report, we have assumed that the PAF tells everything relevant 
about these sources of error. This field of problems is also described in Chapter 8, 
section 8.4. 
2.2.3 Cost-effectiveness analysis  
Cost-benefit and cost-effectiveness analyses are commonly used to compare the 
costs and benefits of alternative measures. In a cost–benefit analysis, costs and ben-
efits are described in monetary terms, while in a cost-effectiveness analysis, costs are 
expressed in monetary units and effectiveness is represented with a non-monetary in-
dicator. In this project, cost-effectiveness calculations are used to assess the effect of 
various policy measures on public health. The status of and impacts on public health 
are described by the commonly used DALYs (WHO 2003), while the costs are calcu-
lated in euros. Such a cost-effectiveness calculation can help to determine how to 
maximize health impacts when financial resources are limited. The method makes it 
possible to compare the relative costs of different measures and to choose the most 
efficient one. In this project, DALY estimations are not converted into monetary terms.  
This cost-effectiveness analysis consists of three steps. First, it defines the costs for 
the current situation—the baseline case. Then it does the same for each of the policy 
options, that is, the different future scenarios. Expenditures considered for the cost 
estimation are monitoring expenses for the Central Food Safety Authorities (including 
the Finnish Food Authority and Customs), for municipalities and for companies. Also 
included in the calculations are the health care expenditures required to treat the 
health impacts caused by exposure to the hazardous substances studied and the cor-
related productivity losses. Depending on the substance, further cost factors might be 
included; these are addressed separately.  
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The cost-effectiveness of an individual measure can be best described by the average 
cost-effectiveness ratio (ACER), as shown in Equation (3): 
𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 = 𝐴𝐴𝐵𝐵𝐶𝐶𝐶𝐶
𝐴𝐴𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐶𝐶
 (3) 
Based on the ACER, it can be shown which scenarios are most effective. It should be 
kept in mind that also the temporal dimension of the analysis is important. Generally 
speaking, actions geared towards children have the greatest potential for cost-effec-
tiveness, as the duration of action in this case is longest (Hutubessy et al. 2003). 
Some actions are cost effective only in the long term, over several decades, while oth-
ers are effective in the short term. In this study, a cost-effectiveness analysis will be 
conducted for 2014–2016. However, a three-year review does not allow long-term im-
pact assessment, which should be taken into account when interpreting the results.  
Monitoring expenditures 
Food safety controls are defined by Finnish law, specifically the 23/2006 Finnish Food 
Act (Elintarvikelaki 23/2006). According to this act, the competent control authorities 
are the Finnish Food Safety Authority (Ruokavirasto), the Regional State Administra-
tive Agencies and the municipal control authorities. The food industry itself also en-
gages in own check to safeguard the quality of their products. Control costs are calcu-
lated at the Finnish level and are therefore comparable to DALY figures. In this pro-
ject, monitoring costs were mapped based on a survey sent to the different monitoring 
authorities.  
Costs for central food safety authorities 
The central food safety authorities refer to the Finnish Food Safety Authority (now the 
Finnish Food Authority) and the Finnish Customs. The costs from Evira and Finnish 
Customs have been collected individually from the actors themselves and are 
summed up in the cost-effectiveness analysis.  
Costs for municipal control authorities 
Municipal control authorities enact food controls at the municipal level. In many cases, 
municipalities have cooperated, leading to the creation of 60 municipal control bodies 
in Finland. All 60 were asked to complete the survey. Eight responded to the survey 
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and provided data regarding their monitoring practices and the related costs. The ob-
tained data set was cleaned, and, where possible, missing values were imputed using 
means. Based on the data, the total monitoring costs per variable can be calculated 
for each respondent. These individual totals consist of three parts (Equation 4):  
𝑇𝑇𝐵𝐵𝐶𝐶𝑇𝑇𝑇𝑇 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 = 𝑇𝑇𝑇𝑇𝑙𝑙𝐵𝐵𝑙𝑙𝑙𝑙 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 + 𝐶𝐶𝑇𝑇𝑠𝑠𝑠𝑠𝑇𝑇𝑠𝑠𝑛𝑛𝑠𝑠 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 + 𝐸𝐸𝐵𝐵𝑛𝑛𝐶𝐶𝑙𝑙𝐵𝐵𝑇𝑇 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶. (4) 
Labour costs refer to the expenses resulting from the authorities’ staff doing their jobs 
(Equation 5). The authorities indicated the time that their staff spent working on food 
safety monitoring activities in total, which was measured in work months per year. 
These were multiplied by the average employee costs (€4,061.667) in the sector, ac-
cording to Statistics Finland. Additionally, the authorities provided information about 
the percentage of time spent on monitoring each of the different hazardous sub-
stances researched. 
𝑌𝑌𝑇𝑇𝑙𝑙𝐵𝐵𝑙𝑙𝑙𝑙 𝐴𝐴𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 = ℎ𝐶𝐶𝑡𝑡𝑡𝑡 𝑠𝑠. 𝑇𝑇.× €4061.667× % 𝐵𝐵𝐸𝐸 𝐶𝐶𝑠𝑠𝑠𝑠𝐸𝐸 𝐶𝐶𝑠𝑠𝐸𝐸𝑛𝑛𝐶𝐶 𝑠𝑠𝐵𝐵𝑛𝑛𝑠𝑠𝐶𝐶𝐵𝐵𝑙𝑙𝑠𝑠𝑛𝑛𝑠𝑠 𝑣𝑣𝑇𝑇𝑙𝑙𝑠𝑠𝑇𝑇𝑙𝑙𝑇𝑇𝐸𝐸 𝑥𝑥 (5) 
Sampling costs include both the costs arising from the actual act of sampling and from 
analysing the samples. Depending on the way in which the municipalities indicated 
their sampling costs, two alternatives were available to compute the sampling costs. If 
the authorities conducted the sampling and analysis themselves, they provided the 
sampling and analysis expenditures individually per hazardous substance investi-
gated. That value was then used (Equation 6a): 
𝑆𝑆𝑇𝑇𝑠𝑠𝑠𝑠𝑇𝑇𝑠𝑠𝑛𝑛𝑠𝑠 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 1 = 𝑆𝑆𝑇𝑇𝑠𝑠𝑠𝑠𝑇𝑇𝑠𝑠𝑛𝑛𝑠𝑠 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 𝑠𝑠𝑛𝑛𝑖𝑖𝑠𝑠𝐸𝐸𝑇𝑇𝐶𝐶𝐸𝐸𝑖𝑖. (6a) 
Alternatively, some municipalities used analysis packages offered by third parties. In 
those cases, the municipalities provided the price per package and the number of var-
iables tested for. To obtain a cost estimate per factor, Equation 6b was applied:  
𝑆𝑆𝑇𝑇𝑠𝑠𝑠𝑠𝑇𝑇𝑠𝑠𝑛𝑛𝑠𝑠 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 2 = 𝑇𝑇𝑛𝑛𝑇𝑇𝑇𝑇𝑎𝑎𝐶𝐶𝑠𝑠𝐶𝐶 𝑠𝑠𝑇𝑇𝐸𝐸𝑡𝑡𝑇𝑇𝑠𝑠𝐸𝐸 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶
𝑛𝑛𝑙𝑙𝑠𝑠𝑙𝑙𝐸𝐸𝑙𝑙 𝐵𝐵𝐸𝐸 𝑣𝑣𝑇𝑇𝑙𝑙𝑠𝑠𝑇𝑇𝑙𝑙𝑇𝑇𝐸𝐸𝐶𝐶 𝑠𝑠𝑛𝑛 𝑠𝑠𝑇𝑇𝐸𝐸𝑡𝑡𝑇𝑇𝑠𝑠𝐸𝐸 . (6b) 
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Finally, control costs were summed for the three-year period 2014–2016. As pre-
sented in Equation 7, the annual costs for controls were estimated:  
𝐴𝐴𝐵𝐵𝑛𝑛𝐶𝐶𝑙𝑙𝐵𝐵𝑇𝑇 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 = 𝑠𝑠𝑛𝑛𝑖𝑖𝑠𝑠𝐸𝐸𝑇𝑇𝐶𝐶𝐸𝐸𝑖𝑖 𝐸𝐸𝐵𝐵𝑛𝑛𝐶𝐶𝑙𝑙𝐵𝐵𝑇𝑇 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶3  . (7) 
To estimate the total cost level for the whole of Finland, the percentage 13.3% (eight 
out of 60 municipalities responded) was used.  
Costs for regional state administrative agencies  
In most cases, Ruokavirasto takes care of these controls. Consequently, regional 
state administrative agencies will not be considered as separate cost-incurring control 
authorities in the analysis.  
Costs for companies 
The methodology is very similar to the one used for municipal control authorities. 
There are approximately 3,100 food business operators of which 35 responded to the 
survey. 
Again, the obtained data was cleaned and completed through imputation. Two compa-
nies were excluded from the analysis due to empty responses, reducing the number 
of usable surveys to 33.  
The total monitoring costs per variable were calculated for each respondent using 
Equation (4). However, the labour costs are higher in the private sector and were ob-
tained using Equation (8): 
𝑌𝑌𝑇𝑇𝑙𝑙𝐵𝐵𝑙𝑙𝑙𝑙 𝐴𝐴𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 = ℎ𝐶𝐶𝑡𝑡𝑡𝑡 𝑠𝑠. 𝑇𝑇.∗ €5200.083 ∗% 𝐵𝐵𝐸𝐸 𝐶𝐶𝑠𝑠𝑠𝑠𝐸𝐸 𝐶𝐶𝑠𝑠𝐸𝐸𝑛𝑛𝐶𝐶 𝑠𝑠𝐵𝐵𝑛𝑛𝑠𝑠𝐶𝐶𝐵𝐵𝑙𝑙𝑠𝑠𝑛𝑛𝑠𝑠 𝑣𝑣𝑇𝑇𝑙𝑙𝑠𝑠𝑇𝑇𝑙𝑙𝑇𝑇𝐸𝐸 𝑥𝑥. (8) 
Sampling costs for companies were calculated in the same way as for municipalities 
using Equations 6a and 6b, depending on how the data was provided. The final part 
comprises control costs, which are also expenses for the companies. The companies 
were asked to indicate their expenses bundled for the chemical, biological and nutri-
tional variables per year. To obtain the separate costs per variable, the bundled costs 
were divided by the number of variables in one category, as shown by Equation 9: 
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𝐴𝐴𝐵𝐵𝑛𝑛𝐶𝐶𝑙𝑙𝐵𝐵𝑇𝑇 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶 = 𝑠𝑠𝑛𝑛𝑖𝑖𝑠𝑠𝐸𝐸𝑇𝑇𝐶𝐶𝐸𝐸𝑖𝑖 𝐸𝐸𝐵𝐵𝑛𝑛𝐶𝐶𝑙𝑙𝐵𝐵𝑇𝑇 𝐸𝐸𝐵𝐵𝐶𝐶𝐶𝐶𝐶𝐶
𝑛𝑛𝑙𝑙𝑠𝑠𝑙𝑙𝐸𝐸𝑙𝑙 𝐵𝐵𝐸𝐸 𝑣𝑣𝑇𝑇𝑙𝑙𝑠𝑠𝑇𝑇𝑙𝑙𝑇𝑇𝐸𝐸𝐶𝐶 𝑠𝑠𝑛𝑛 𝐸𝐸𝑇𝑇𝐶𝐶𝐸𝐸𝑠𝑠𝐵𝐵𝑙𝑙𝑎𝑎 (9) 
Equivalent to the case of the municipalities, the total costs per variable and per com-
pany were calculated by summing up the different cost categories. To estimate the 
national annual control costs per variable, the costs needed to be scaled. Based on 
the Finnish Food Authority’s registry of companies active in the Finnish food sector, 
4,791 companies were identified. The number does not include retail or catering com-
panies. Using this as an estimation of companies in the food sector having to monitor 
at least some of the substances studied in this research gives a percentage of 0.69%. 
The company costs calculated in the project are a rough estimate.  
Current situation and future scenarios 
To conduct a cost-effectiveness analysis, it is necessary to compare the current level 
costs to the costs anticipated in future scenarios. Both costs were assessed following 
the same scheme, combing monitoring costs, health care costs connected to the sub-
stance, productivity losses and, where necessary, other costs. The way the costs are 
calculated is explained in the substance-specific sections (Chapters 3–6).  
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3 Biological hazards: Examples, 
current status and scenarios 
This chapter goes through the examples of biological food hazards explored in the 
RUORI project. For each example, the report describes its impact on consumer 
health, its prevalence in food, information on the exposure (intake) and related mor-
bidity of the population living in Finland, the BoD associated with the hazard and the 
current costs of surveillance and morbidity. After presenting the current situation, the 
scenario studied in the project and its impact on disease burden and costs will be de-
scribed. 
Detailed assumptions and calculation codes used to calculate disease burden esti-
mates can be found on the Opasnet Web Workspace RUORI page at 
http://fi.opasnet.org/fi/Ruori  
3.1 Listeria monocytogenes 
3.1.1 Health effects 
Listeria is a species of pathogenic bacteria that causes a serious disease called lister-
iosis in humans. Listeriosis carries a mortality rate of about 20%–30% in at-risk 
groups (Barbuddhe & Chakraborty 2009). Pregnant women, the elderly, newborns, 
transplant patients and others with reduced immunity are at risk for listeriosis. In peo-
ple with impaired immunity, Listeria usually causes serious illness, such as meningitis 
or encephalitis and/or sepsis, which can be fatal (Doganay 2003). In pregnant women, 
listeriosis manifests as a mild illness that resembles the common flu (fever, chills, 
muscle aches and headaches) and can lead to miscarriage or premature labour 
(Doganay 2003; Farber & Peterkin 1991). In neonates, the disease manifests as sep-
sis in labour or as meningitis later. In healthy adults and children, Listeria does not 
usually cause symptoms, but foods high in Listeria can cause self-limiting gastroenter-
itis. Generally, the onset of symptoms occurs with a high dose of Listeria (100,000–1 
VALTIONEUVOSTON SELVITYS- JA TUTKIMUSTOIMINNAN JULKAISUSARJA 2019:X 
 
30 
 
 
million colony forming units/g [cfu/g]). However, very low concentrations (even less 
than 10–10,000 cfu/g) have been reported to cause illness in at-risk groups (Hallan-
vuo & Johansson 2010). 
3.1.2 Prevalence in food and current status in Fin-
land 
Listeriosis is mainly a foodborne infection associated with inadequately heated or con-
taminated food, particularly fish and fish products, meat and meat products, vegeta-
bles and milk and milk products (Hallanvuo & Johansson 2010). 
High-risk foods include those which are eaten without being heated, have a long 
shelf-life and are able to support the growth of Listeria. Such foods include vacuum-
packed, cold-smoked and salt-cured fish products; eggs; meat, cold cuts and pâtés; 
frozen vegetables; and unpasteurized milk and cheese (Hallanvuo & Johansson 
2010). Listeria is also able to grow at refrigerator temperatures, meaning that even a 
small amount of Listeria in food can grow to harmful concentrations (Farber & Peter-
kin 1991). The ability to grow in a cold and low-oxygen environment allows Listeria to 
grow to high concentrations while preventing other microbes from growing. In addi-
tion, Listeria can form stable biofilms that can cause Listeria contamination to be a 
highly persistent problem in manufacturing plants. 
Controlling Listeria in food is the responsibility of the food business operator. Sam-
pling is mainly focused on ready-to-eat (RTE) food. Listeria bacteria are destroyed 
during heat treatment, so testing foods intended for heating would not make sense. 
According to the Microbial Criteria Regulation (EC) 2073/2005, samples are taken 
from RTE foods at meat, fish, dairy, and egg product establishments, food establish-
ments producing vegetable (including sprouts) and fruit products and bakeries. The 
production environment should also be monitored for the presence of Listeria. If a 
batch of food does not meet the Microbial Criteria Regulation targets, the batch is 
withdrawn from the market. Depending on the sample, the detection of Listeria leads 
to power cleaning to sampling and withdrawal. 
Listeriosis is classified as an infectious disease to be controlled according to the Infec-
tious Diseases Regulation, and clinical laboratories are required to report the finding 
of L. monocytogenes. Listeriosis is more common in Finland than elsewhere in Eu-
rope (EFSA, ECDC 2017). Between 2014 and 2016, a total of 177 listeriosis cases 
were reported to the Registry of Infectious Diseases (on average 59 a year). The me-
dian age of those infected was 75 years (range 0–96 years) (Figure 2). Of the cases, 
51% (90/177) were women, and 21% of cases died within 30 days of sampling. Infor-
mation on pregnancy was not reported in the infectious disease register, but based on 
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laboratory notifications there was one neonatal listeriosis case in 2014, and based on 
patient interviews in 2016 there was one pregnancy-associated Listeria infection (THL 
2015, THL 2017b). 
 
Figure 2. Listeriosis cases in Finland per 100,000 people annually and by age group. In older age groups, 
the incidence is clearly higher than the average for the whole population. Source: THL Register of Infectious 
Diseases. 
3.1.3 Current burden of disease caused by Listeria 
The WHO report (2015) estimates that Listeria causes an average BoD of 2 DALYs/ 
100,000 people in Europe (range 1–4 DALYs). The incidence used in the WHO esti-
mate, 0.2 cases per 100,000 persons, is approximately six times lower than that in the 
Finnish registry data, as 46–66 cases were reported per year in 2014–2016 (see Fig-
ure 2). 
According to WHO, one case corresponds to a burden of 10 DALYs. If the WHO esti-
mate is used as is and is scaled to correspond to the number of cases in the Finnish 
registers, the burden of Listeria disease in Finland will be 650, 460 and 660 DALYs in 
2014, 2015 and 2016, respectively. 
Estimated distributions for various sequelae and the age distribution of the dead used 
by WHO differ somewhat from those of Finland, but the mortality distribution of 21% 
corresponds to Listeria mortality reported in Finland. The BoD essentially consists of 
years of life lost due to deaths. Calculated using the RUORI model, Listeria caused 
670 (400–950) DALYs/year. 
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3.1.4 Costs related to surveillance and morbidity  
Of the annual regulatory control working time, 1%–10% was spent on Listeria. Only 
one of the responding authorities reported that during the 2014–2016 official control 
they found food samples that were not allowed (i.e. exceeded the maximum level). 
Control authorities called for control actions at companies mostly because of Listeria. 
The appendices of the Finnish Food Authority’s guideline document “Elintarvikkeiden 
mikrobiologiset vaatimukset toimijoille ohje 10501/2” (Evira 2017c) describe the sam-
pling frequencies for own-checks in different food establishments. Sampling frequency 
(0–24 times a year) is influenced by, among other things, the type of food, the ability 
of Listeria to grow in the product and the amount of annual production. The control au-
thority may lighten the sampling requirement based on good results (Evira, 2017c). 
Cost estimates were based on average sample sizes for different types of plants. 
The cost of a visit to a health centre is €96. Of those with listeriosis, 76% had blood 
poisoning for which treatment costs are €6,207/case based on data collected by THL, 
and 14% were treated for meningitis for €7,081/case. As a result, the annual cost of 
detecting and treating listeriosis was approximately €342,000. 
Listeria has to be monitored according to EU Commission Regulation No. 2073/2005. 
As such, costs result from monitoring by companies and authorities. Additionally, 
health care and productivity losses cause expenses. 
Table 1. Costs associated with Listeria 
Listeria current situation, costs (thousand €)  
Labour  Sampling  Control  Total  
Finnish Food Authority and Customs    -  
Municipal Control Authorities 457 9 15 481  
Companies Not included 5,060 Not included 5,060 
Health Care Costs    342 
Productivity Loss    30 
Total 457 5,068 15 5,913 
Listeria is one of the most commonly controlled factors, as 100% of the responding 
municipalities control it. The monitoring expenses vary greatly, ranging between €60 
and €34,500 annually. This leads to an estimation of €491,000 in monitoring costs in-
curred annually by municipalities. The major part of their expenses are made up of la-
bour costs. The same applies for companies (approximately 70%). In this project, the 
focus is on the company analysis costs, as the envisioned scenario concentrates on 
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the number of analysis incidences engineered. The estimation is that almost 43,500 
sample analyses need to be conducted in Finland annually. According to the Finnish 
Food Authority, the analysis per sample costs €116.32. Taking this price as an esti-
mation of average sample analysis costs in the industry, the total cost for companies 
is €5.1 million.  
Regarding health care costs, it was taken into account that on average 59 listeriosis 
cases occurred annually in the reference period 2014–2016 (THL 2015, 2016c, 
2017b). It is assumed that at least one health care visit per case took place, which 
costs €96. In addition, it is known that 76% of the infected patients developed sepsis. 
On average, sepsis costs €6,207 and usually requires 10.3 treatment days. Another 
14% of the infected patients developed meningitis, which typically requires 10.1 treat-
ment days and has a total cost of €7,801 (Nakari ym. 2014, THL 2014b). Added to-
gether, listeriosis treatment costs are €342,000 annually. Estimating the productivity 
loss requires knowledge about the age structure of the infected patients. According to 
THL (THL Report 11/2017, p. 21), the median patient age was 74, and 67.2% of the 
patients were over 64 (THL 2017c). Correspondingly, only about 32.8% or 19 people 
were of working age. Assuming that the sepsis and meningitis incidence percentage 
is the same in this age group implies a total of 179 sick days. At a productivity loss of 
€168/day, this corresponds to €30,000 (THL 2014b). The total health effect costs add 
up to €372,000 annually (Table 1). 
Taken altogether, the occurrence of Listeria and its prevention costs at least €5.9 mil-
lion annually. This estimation excludes company labour costs, company sampling 
costs and company control costs and is therefore a clear underestimation of the true 
total costs. 
3.1.5 Scenario 
As a scenario to reduce the BoD due to Listeria, all establishments in the meat and 
fish sector, cheese dairies and premises producing or importing vegetable and fruit 
products take samples from the production environment in addition to samples taken 
as prescribed by the Microbial Criteria Regulation. As many samples are taken yearly 
from the production environment as the products are presently sampled, and five 
samples or more are sampled at a time, according to the Microbial Criteria Regula-
tion. All positive batches will be rejected. 
The scenario was chosen for the following reasons. The BoD arises from Listeria 
deaths, which could be prevented by controlling infections. The purpose of this sce-
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nario is to reduce the number of products contaminated with Listeria and thus to re-
duce the incidence of listeriosis. In the scenario, a decrease in the BoD caused by 
Listeria is the ideal case; however, sampling, cleaning and renovation costs increase. 
To determine the cost-effectiveness of the current state and the scenario, a calcula-
tion was developed that included meat production facilities, fish establishments, 
cheese dairies and premises producing raw, cut, grated or otherwise processed vege-
table and fruit products. As in the present situation, plant size and production quality 
will determine the sampling frequency of the products and will also affect the sampling 
frequency of the production environment. 
In the calculation, the current sample numbers for Listeria were assumed to be the 
same as the average sample numbers for products and production environments in 
the Finnish Food Authority's guideline. The cost of sampling was calculated according 
to the price of the Finnish Food Authority’s Listeria assay. This does not take into ac-
count other costs of sampling, such as staff costs and analysis equipment costs, but 
the assumption is that food business operators may conduct a Listeria survey for a 
lower price than that of a single sample analysed at the Finnish Food Authority. The 
price was not calculated for the rejection of Listeria-positive batches because it is not 
known how large the batches are and what value they have. All Listeria strains found 
in the food chain should be submitted to the Finnish Food Authority; in 2011–2018, an 
average of 479 strains were delivered annually. The cost of additional sampling due to 
a positive Listeria finding was not included in the scenario. 
3.1.6 Cost-effectiveness and impact of the scenario 
on burden of disease 
If the risk mitigation measures in the scenario would eradicate listeriosis in Finland, 
the BoD would decrease by 670 DALYs/year (range 400–950). Health benefits would 
be significant, based on an optimistic estimate that the measures would be sufficient 
for eradication. The probability of this was not assessed, but only the assumed inter-
ventions, effects and their costs were used. As the analytic sampling can only target a 
limited random sample of all products and production batches, even the best random 
testing can find contamination with a probability that is the product of true prevalence 
and sampling percentage, assuming random contamination in the production. For ex-
ample, in cold-smoked fish products, the prevalence has been estimated to be 
roughly 20%. When the sampling percentage is X%, the residual prevalence would be 
20%*(100%-X%). However, possible uneven clustering of contamination and sam-
pling can affect this in ways that are not possible to assess using current information. 
In the scenario, the theoretical maximum for disease burden reduction was calculated. 
The realistic estimate strongly depends on the size of the batches of food and how 
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many batches are being studied, and this information was not available to the project. 
Instead of a 100% reduction, the actual reduction may be only a fraction of that. Fur-
ther investigation is needed in this area. 
Therefore, it is not possible to estimate by how much the DALYs would really de-
crease, but the assumption was that there would be a maximum effect, that is, the 
DALYs become zero. 
Table 2. Costs associated with the Listeria scenario 
Listeria scenario, costs (thousand €) 
  Labour  Sampling Control Total 
Finnish Food Authority 
and Customs 
      - 
Municipal Control 
Authorities 
457 9 15 481 
Companies Not included 6,460 Not included 6,460 
Health Care Costs       - 
Productivity Loss       - 
Total 457 6,469 15 6,941  
Companies have to conduct 12,000 additional analyses, with each analysis costing 
€116.32 (Finnish Food Authority 2019g). The extra costs of the scenario are thus at 
least €1.4 million annually. Again, it is crucial to remember that these extra costs refer 
exclusively to the analysis costs. It was already pointed out that not enough infor-
mation about the cost distribution in companies is available to estimate all cost impli-
cations, as other cost aspects might increase as well. The health impact costs are 
easily described, as they follow the assumption that the additional controls manage to 
reduce the DALYs level to zero. Zero DALYs implies no health care costs or produc-
tivity losses (Table 2). 
In summary, the additional costs of the Listeria scenario are about €1 million, with the 
expectation that the DALYs level decreases to zero. The changes resulting from the 
scenario are presented in Table 3. 
Table 3. Summary of Listeria current status and scenario 
Listeria 
  Current situation Scenario Change 
DALYs 670 0 -670 
Costs (thousand €) 5,913 6,941 1,028 
  ACER 1,534 €/DALY 
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3.2 Norovirus 
3.2.1 Health effects 
Norovirus has been the most commonly reported cause of food poisoning in Finland 
since 1997 (Hallanvuo & Johansson 2010). Humans are the only known hosts for no-
rovirus, although other animals are known to have similar viruses. Therefore, no-
rovirus infection always requires a person as a source, either direct or indirect. No-
rovirus is transmitted feco-orally and causes clusters of disease (Terveyskirjasto 
2017). A very small amount, even less than 10–100 viral particles, is enough to cause 
illness. By way of illustration, there are billions of viral particles/g of diarrhea (Patel et 
al. 2009; Terveyskirjasto 2017). Illness can also be contracted through contact with 
the aerosols produced during vomiting (Patel et al. 2009). 
Norovirus can be contracted throughout the year (Patel et al. 2009), but in Finland 
most cases are reported from November to March (Terveyskirjasto 2017). Symptoms 
typically begin 6–48 hours after exposure. Symptoms include the sudden onset of ma-
laise, vomiting (50%–90% of patients), diarrhea (50%–90% of patients), abdominal 
pain (40%–70% of patients), fever (37%–45% of patients) and muscle pain (Patel et 
al. 2009; Simonsson et al. 2014). Symptoms typically last 2–4 days, but in immuno-
compromised people the symptoms may last significantly longer. Mortality is low, par-
ticularly in developed countries (Simonsson et al. 2014). Norovirus infections are 
clearly underreported, as the disease usually disappears on its own and patient sam-
ples are seldom taken (Harris et al. 2017; Terveyskirjasto 2017). 
3.2.2 Prevalence in food and current status in Fin-
land 
Norovirus is easily transmitted from an infected person through food (Hallanvuo & Jo-
hansson 2010). In 2014–2016, 62% of the foodborne outbreaks were either caused or 
suspected to be caused by norovirus transmitted from an infected worker to food 
(Pihlajasaari et al. 2019). Norovirus has been associated with uncooked vegetables, 
such as frozen berries imported from abroad, mussels and oysters (Hallanvuo & Jo-
hansson 2010; Health Library 2017). When frozen, norovirus remains infectious for up 
to years. However, it is destroyed by heating food to temperatures above 90 °C for at 
least two minutes (Finnish Food Authority 2019) 
Norovirus is one of the other reported microbial findings in the Infectious Disease 
Regulation; therefore, clinical laboratories are required to report any finding. In 2016, 
41 (46%) of the 89 suspected foodborne outbreaks reported in the THL and Evira 
Common Register Information System (RYMY) were considered to be norovirus (THL 
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2017). Norovirus is also the most common cause of waterborne outbreaks in Finland 
(Zacheus & Miettinen 2011). In 2014–2016, 5,922 cases of norovirus were reported to 
the Registry of Infectious Diseases, with the median age being 75 (range 0–108) (Fig-
ure 3). This reflects the proportion of the population sampled rather than the occur-
rence of the disease. Indeed, short-term vomiting and diarrhea in healthy individuals 
are treated symptomatically, regardless of the underlying pathogen. In addition, ac-
cording to a study by Tam et al. (2012), about 94% of Britons with norovirus infection 
do not seek treatment. Of the cases listed in the communicable disease register, 57% 
were women (THL 2015; THL 2017). Figure 4 shows the food sources of norovirus in-
fection in 2014–2016. 
 
 
Figure 3. Finnish cases of norovirus per 100,000 people annually and by age group. Source: THL Register of 
Infectious Diseases. 
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Figure 4. Identified food sources of norovirus infections in 2014–2016. Only about a quarter of the cases 
caused by food could be connected with a specific product. 
3.2.3 Current burden of disease caused by norovirus 
WHO estimates that foodborne norovirus caused a BoD in Europe of 4 
DALYs/100,000 in 2010 (95% confidence interval 1–8 DALYs/100,000) (WHO 2015). 
In Finland, this would correspond to a BoD of about 220 DALYs (55–440 DALYs). 
However, WHO calculations for Finland use the median of the overall case estimate 
for Europe, which was 1,652/100,000. This is a multi-fold estimate compared to the 
cases reported in the Register of Communicable Diseases (1,363; 2,164; and 2,395 
cases in 2014–2016). However, there is no reliable quantitative information on un-
derreporting in the communicable disease register; therefore, WHO figures have been 
used in the assessment. 
It is not known how many of the cases reported in the communicable disease register 
originate from food. Evira and THL report on foodborne outbreaks in 2011–2013 
(Pihlajasaari et al. 2016) found that 51% were related to eating in restaurants. The 
most commonly identified cause was norovirus, which was responsible for 20 out-
breaks (30% of restaurant-related outbreaks). Of the 131 foodborne outbreaks de-
tected during the reporting period, 48% of the 2,796 people affected were infected 
with norovirus. An infected food worker was responsible for 64% of the reported food-
borne norovirus epidemics involving more than 900 people. 
When using the actual case numbers according to the Finnish Register of Infectious 
Diseases, the above formula and the WHO disease duration (2 days on average, 1–4 
days confidence interval) and the disability weight factor (severe 0.281 [0.184–0.399], 
mean 0.202 [0.132] and mild 0.061 [0.036–0.093]) can be calculated for 2014–2016. 
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According to WHO estimates, 0.5% of cases are severe, 8.5% are moderate and the 
remaining 91% are mild. It should be noted that in this calculation, no person is as-
sumed to have died of norovirus. Based on this baseline, the burden of norovirus dis-
ease was estimated at 200 (73–430) DALYs/year. 
3.2.4 Costs related to surveillance and morbidity 
Norovirus is currently monitored only in connection with outbreak investigations. Ac-
cording to a survey, municipal authorities spent between 2% and 10% of their annual 
working time monitoring norovirus. 
The Finnish Food Authority recommends that food workers infected with norovirus 
take a sufficiently long sick leave, that is, 1–2 symptomless days after the visible 
symptoms. As the virus is still secreted after this, the worker must be particularly care-
ful with hygienic practices or, where possible, should temporarily switch to tasks that 
do not involve contact with food. 
An average of 1,973 cases of norovirus per year were recorded in the communicable 
disease register in 2014–2016. The cost of a visit to a health care centre to receive 
primary care is €72 for norovirus infection. Of those with norovirus infection, 94% do 
not seek treatment (Tam et al. 2012) and therefore do not end up in the registry. Of 
the norovirus cases in 2014–2016, 2% applied for emergency care and 0.3%–13% 
were admitted to hospital. The cost for inpatient care is €213/case. 
In the case of norovirus, the costs consist solely of the cost of monitoring the munici-
palities and the cost of health care. Because companies do not appear to control for 
norovirus, the overall cost in this case remains relatively low. 
Table 4. Norovirus-related costs 
Norovirus current status, costs (thousand €) 
  Labour  Sampling  Inspection  Total  
Food Authority and Customs       -  
Municipalities 474  13  5 491  
Companies        -  
Health care costs       204  
Loss of productivity       6,696  
Total costs 474 13 5  7,391  
There are no statutory obligations to control norovirus. The municipalities’ annual 
monitoring costs are €490,000. It is unclear whether these costs are the costs of on-
going monitoring or of epidemics. About 95% of the total costs are labour costs (Table 
4). 
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Estimating health care costs is difficult, as only about 6% of cases are reported (Tam 
et al. 2012). Most cases are resolved through home care. THL registered 1,973 cases 
in Finland in 2014–2016. This means there are an estimated 32,900 cases of no-
rovirus in Finland each year. Health care costs were assessed separately for reported 
and unreported cases. The number of registered cases, 1,973, means at least one 
visit to a doctor (THL 2015, 2016c, 2017b). THL estimates this to cost €72. The cost 
of hospitalization is €234/day, and it was estimated that 6.65% of patients will be hos-
pitalized (THL 2014b). Due to the short duration of the norovirus (12–72 h) (THL 
2016b), one visit to the doctor and a 2-day hospital stay were used in the calculations. 
Other costs have not been taken into account, as there is no actual treatment for no-
rovirus (RKI 2019). Total health care costs are €204,000 annually. There are no 
health care costs for unregistered cases, but both registered and unregistered cases 
result in loss of productivity. Food workers are advised to stay home for 2 days after 
symptoms disappear (THL 2016b). Thus, it was estimated that an average infection 
would result in a loss of 2.5 working days at €168 (THL 2014b). In addition, 47% of in-
fections occur in people over 75 who are no longer active in the labour market. There-
fore, it is estimated that 15,455 people of working age contract norovirus every year. 
Note that this figure also includes children who were supposed to have parents stay-
ing home to care for them. The loss in productivity is thus €6.7 million/year (Table 4). 
The total cost of norovirus is €7.4 million/year, most of which is lost productivity. 
3.2.5 Scenario  
As a scenario to reduce the BoD caused by norovirus, surface samples were taken 
monthly from November to March from food lines, catering kitchens and other food es-
tablishments producing RTE food. Five samples per month would be taken from the 
kitchens and staff rooms of commercial kitchens, and five samples twice per month 
would be taken from food production lines and staff rooms of other food premises. 
The scenario was chosen for the following reasons. Sampling and cleaning following 
positive results would reduce the number of norovirus outbreaks because norovirus is 
a problem, particularly when it ends up in RTE products. Based on surface purity 
samples, cleaning can be enhanced at the right time. The scenario assumed that 35% 
of norovirus infections are due to a foodborne outbreak caused by a food worker, so 
its theoretical maximum efficacy would be this. The actual impact would probably be 
weaker. 
Currently, surface cleanliness samples are only taken in the context of outbreak in-
vestigations, which increases the cost of sampling in the scenario. Samples were 
priced at the University of Helsinki analysis price of €300 for five samples. 
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3.2.6 Cost-effectiveness and impact of the scenario 
on burden of disease  
The effect of the norovirus scenario was estimated to reduce BoD by 23 DALYs/year 
(95% CI 0.7–80 DALYs/year). The effect is only a tenth of the total burden of the dis-
ease, as only some of the disease cases are transmitted through food. The measures 
are expected to prevent half of the foodborne outbreaks. 
Norovirus outbreaks occur most frequently in November through March, and the 
source is often food. In the proposed scenario, surface samples will be taken from the 
cooking areas and premises of personnel. The measures would be implemented in 
restaurants, canteens and companies producing RTE food. The scenario assumes 
that the result would be a 35% reduction in norovirus cases. 
Table 5. Norovirus scenario-related costs 
Norovirus scenario, costs (thousand €) 
  Labour  Sampling Inspection Total  
Food Authority and Customs    -  
Municipalities 308 8 3 319 
Companies    23,934 
Health care costs    134 
Loss of productivity    4,353 
Total costs 308 8 3 28,740 
The companies pay all the control costs, and these costs form the bulk of the costs of 
the scenario. For the purpose of calculating the total cost, the number of sites, the 
number of samples and the cost of one sampling were estimated. The cost of one 
sample was €74.40, based on University of Helsinki data (University of Helsinki 2019). 
The number of samples was calculated as follows. In the RTE food sector, 15 sam-
ples will be taken twice a month for five months (November–March). The companies 
have an average of two production lines, so the total number of samples will be 
150/item. According to the Food Authority, there are 478 sites in the industry, so a to-
tal of 72,000 samples will be taken. In restaurants and canteens, 25 samples will be 
taken during the control period, five samples/company/month. In 2014–2016, the 
number of these sites was 10,000, so a total of 250,000 samples will be taken in can-
teens and restaurants (MARA 2018). The cost increase is obtained by multiplying the 
number of samples by its unit cost, resulting in an additional cost of €24 million. For 
an individual company, the additional cost is between €860 and €11,160. It should be 
noted that cost reduction is not affected by disease reduction (Table 5). 
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Here, it was assumed that both municipal control and health care would result in sav-
ings of 35% for norovirus cases. For municipalities, the savings would be €172,000 
and €2.4 million in productivity gains in health care. 
The total additional cost of the scenario is €21 million, assuming a 35% reduction in 
morbidity. If the impact of the measures was less significant, the cost estimate would 
also increase. If illness is not reduced at all, the extra cost would be almost €24 mil-
lion. A summary of the change from the current status to the scenario is presented in 
Table 6. 
Table 6. Summary of norovirus current status and scenario 
Norovirus 
  Current status Scenario Difference 
DALYs 220 197 -23 
Costs (thousand €) 7,391 28,740 21,349 
  ACER 928,209 €/DALY 
 
3.3 Toxoplasma 
3.3.1 Health effects 
Toxoplasma gondii is a protozoan that causes an infection in humans called toxoplas-
mosis (Terveyskirjasto 2018). T. gondii lives in feline intestinal mucosa cells. A cat is 
typically infected by eating a small rodent or bird that has parasites in its tissues or is 
directly infected from the feces of another cat. As a result of the sexual reproduction 
of toxoplasma in the gut, up to 10 million oocysts/day are excreted in the cat’s feces 
for approximately several weeks. Oocysts, which are environmentally resistant, be-
come infectious under favourable conditions in less than 5 days and can remain in the 
soil for more than a year, polluting waterways and infecting animals. The infectious 
dose of T. gondii is approximately 10–100 oocysts (Hallanvuo & Johansson 2010). 
In humans, toxoplasma infection is usually asymptomatic or causes a mild fever. This 
may be accompanied by night sweats, fatigue and muscle aches. Symptoms start 
about 2 weeks (10–21 days) after infection. Fever-free lymph node enlargement is the 
most common symptom (Terveyskirjasto 2018). In immunocompromised people, toxo-
plasmosis can cause inflammation of the brain, inflammation of the retina, pneumonia 
and other kinds of organ damage (Hallanvuo & Johansson 2010). A mother’s recent 
infection with toxoplasma during pregnancy poses a serious risk to the fetus and child. 
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Particularly in early pregnancy, infection may result in miscarriage or serious perma-
nent injury to the child, such as vision, hearing and brain damage or feverish infec-
tions. In most cases, congenital toxoplasmosis manifests as inflammation of the retina 
in newborns. Other disorders include epilepsy, problems with physical activity and in-
tellectual disabilities. 
Diagnosing congenital toxoplasma infection is difficult, and only about 10% of cases 
are diagnosed if the disease is investigated after birth (Lappalainen & Koskiniemi 
1988, Koskiniemi et al. 1989). However, it is a treatable disease (McCabe & Reming-
ton 1983; Couvreur et al. 1988; Daffos et al. 1988; Remington & Desmonts 1990). 
Nine out of 10 congenitally infected children go undiagnosed and untreated, and the 
disease may progress for years, causing visual, hearing and brain damage (Alford et 
al. 1974; Wilson et al. 1980; Koppe et al. 1986). However, pre-pregnancy infection is 
not harmful to the fetus and does not increase the risk of miscarriage. Toxoplasma re-
mains permanently in human cells after infection, typically in the retina (Health Library 
2018). Detecting infection during pregnancy and initiating treatment reduce the inci-
dence of congenital toxoplasmosis by about half and alleviate the symptoms of the 
disease (Koskiniemi 1993). 
3.3.2 Prevalence in food and current status in Fin-
land 
In addition to the above-mentioned rodent–cat–cat feces pathway, toxoplasma occurs 
in the form of vesicles in the tissues of several mammals, such as sheep, cattle and 
pigs. Most people are infected by consuming insufficiently cooked meat, cat feces or 
food contaminated with cat feces (Terveyskirjasto 2018). The majority of toxoplasma 
infections are believed to be explained by consuming insufficiently cooked meat 
(Cook et al. 2000). 
The Infectious Diseases Regulation classifies T. gondii as a notifiable microbial find-
ing; therefore, clinical laboratories are required to report the finding. In 2014–2016, 98 
cases of toxoplasmosis were record in the Registry of Infectious Diseases, most of 
which were identified by finding antibodies. The median age of patients was 39 (range 
0–90). The WHO (2015) estimates the incidence of toxoplasmosis in Europe to be 
119 (77–188)/100,000 person years. For adults, a higher rate was used because un-
derreporting causes an unknown, risk-diminishing bias in the communicable disease 
registry. According to a study based on the appearance of antibodies during preg-
nancy, it is estimated that approximately 130 women each year experience fresh toxo-
plasma infection. When only about 1 in 10 infections of a mother pass through the pla-
centa to the child, congenital diseases are likely to occur only 10–15 times every year 
(Lumio 2018). 
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3.3.3 Current burden of disease caused by toxo-
plasma 
Registry data for infections caused by toxoplasma have been found to be so unrelia-
ble that they do not allow for a national calculation of WHO BoD. In fact, it is not 
known from the Finnish register of infectious diseases what percentage of the infec-
tions were acquired from food and other sources, such as cat feces. 
The WHO report (WHO 2015 Table A8.2) presents the dietary incidence of T. gondii 
and the BoD/100,000 people. When these values are proportional to the Finnish pop-
ulation (5.49 million people, Statistics Finland 2016) values for morbidity and BoD are 
obtained. 
Table 7. Foodborne cases of toxoplasmosis in Finland, calculated according to the incidence in 
the European territory. The burden of disease estimates are from the RUORI model. Congenital re-
fers to the infection of the mother during the pregnancy, while acquired refers to infection ac-
quired later through foodborne illness. 
 Congenital Acquired 
 Median 95 % confidence 
interval 
Median 95 % confidence 
interval 
Morbidity 16.5 10.8–37.8 6,530 4,335–10,316 
Deaths 0.27 0.108–0.54 0 0–0 
Burden of disease (DALY) 110 47–250 320 150–590 
 
The case count values of these calculations are several hundred times higher than 
those of the Infectious Disease Registry (23, 40 and 35 cases in 2014–2016). It is 
likely that the actual morbidity and burden of foodborne toxoplasma in Finland is be-
tween that listed in the Infectious Diseases Registry and the WHO European esti-
mate. 
3.3.4 Costs related to surveillance and morbidity 
Currently, toxoplasma is not monitored in food. For uncooked meat, freezing long 
enough at a sufficiently cold temperature is an effective means of destroying para-
sites. Adequate heating also kills the parasites. At-risk groups, particularly pregnant 
women, should be advised on how to avoid toxoplasma (Hallanvuo & Johansson 
2010). In 2014–2016, 98 cases of toxoplasmosis were recorded in the communicable 
disease register. The annual cost of monitoring for toxoplasma is €12 million. 
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Table 8. Toxoplasma-related costs 
Toxoplasma current status, costs (thousand €) 
  Labour Sampling Inspection Total  
Food Authority and Customs - - -  -  
Municipalities 51 -  0.2 51 
Companies 30 15 11,869 11,913 
Health care costs         
Loss of productivity         
Total costs 81 15 11,869 11,964 
Monitoring toxoplasma is not very common; only 13% of municipalities and 9% of 
companies monitor it. In addition, it appears to be relatively cheap for municipalities 
and companies alike in comparison to other hazardous substances. Due to the limited 
cost data related to toxoplasma, it is difficult to make reliable estimates of the total 
cost. The cost for municipalities is €51,000 annually, 100% of which are labour costs. 
The cost for businesses is €12 million, with almost 100% being control costs (Table 
8). 
Health care costs come from two sources. First, the toxoplasmosis acquired after birth 
can be from food, soil or cat feces. WHO estimates that 95% of toxoplasma infections 
are overlooked (WHO 2016). In the remaining 5%, symptoms range from mild fever to 
effects on viscera (RKI 2018). However, these costs and effects are difficult to deter-
mine. Therefore, the focus is on congenital toxoplasmosis. 
Congenital toxoplasmosis is acquired during pregnancy, with an average of 17 cases 
each year. Health effects vary depending on the stage of pregnancy when the mother 
acquires toxoplasmosis. During the first trimester, it can lead to miscarriage or need to 
have an abortion, the cost of which is not estimated here. Toxoplasmosis acquired at 
a later stage usually causes ocular and retinal inflammation, which can result in blind-
ness and brain dysfunction (RKI 2018). Newborns have to be treated with two differ-
ent antimicrobials for one year (American Academy of Ophthalmology 2019). Here, it 
was assumed that newborns are monitored monthly at a cost of €19,600, while the 
unit cost of a health centre visit is €96 (THL 2014b). The cost of the drug is approxi-
mately €598/patient. The total cost of health care is therefore €29,800 (Table 6). It is 
also assumed that one of the parents is on parental leave so that there is no loss of 
productivity. Of course, symptoms may also occur at a later age, but their cost cannot 
be estimated here. 
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3.3.5 Scenario  
The reduction of the burden of toxoplasma-related disease was studied in a scenario 
where all pregnant women are tested for toxoplasma via an antibody test. The sce-
nario assumes that all congenital disease cases will be detected and treated. In addi-
tion, all pregnant mothers are given guidance on how to avoid becoming infected. 
The scenario was chosen for the following reasons. According to the WHO BoD as-
sessment, toxoplasmosis is the third most important foodborne pathogen in Europe 
and can cause severe fetal damage. The detection of primary toxoplasma infection 
during pregnancy and the initiation of specific therapy reduces the incidence of con-
genital toxoplasmosis by approximately half and alleviates the symptoms of the dis-
ease (Koskiniemi 1993). However, most cases of toxoplasmosis are not congenitally 
acquired; rather transmission occurs through direct food exposure. 
Currently, there are no food risk management guidelines in Finland relating to toxo-
plasma and no monitoring for toxoplasma antibodies during pregnancy. Therefore, the 
scenario would increase the cost of sampling, even if the cost of morbidity is reduced. 
The cost of one antibody assay is €30–€40, and the average birth rate was 55,000 
children/year in 2014–2016. 
 
3.3.6 Cost-effectiveness and impact of the scenario 
on burden of disease  
The toxoplasma scenario was estimated to reduce the BoD for Finns by 120 
DALYs/year (95% confidence interval, 47–250 DALYs/year). Congenital toxoplasmo-
sis causes serious illness in a few people, so the scenario would be very effective for 
them if implemented as planned. However, the scenario does not help to reduce the 
amount of toxoplasmosis acquired. 
According to the scenario, all pregnant women are tested for toxoplasmosis. It is as-
sumed that congenital diseases will no longer be present. 
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Table 9. Toxoplasma scenario-related costs  
Toxoplasma scenario, costs (thousand €) 
  Labour  Sampling Inspection Total  
Food Authority and Customs         
Municipalities 51 -  0.2 51 
Companies 30 15 11,869 11,913 
Health care costs       2,226 
Loss of productivity         
Total costs 81 15 11,869 14,191 
The toxoplasmosis test is performed during weeks 8–10 of pregnancy at the first visit 
to a prenatal clinic (RKI 2018). To estimate the number of pregnancies, the number of 
deliveries is first calculated, and the number of miscarriages must be known. About 
15% of pregnancies end in miscarriage, most in the first trimester of pregnancy (HUS 
2019). In the absence of more specific information, it is assumed that all pregnant 
women who will subsequently have a miscarriage are also being tested. The number 
of births is 55,173, plus the number of stillbirths (163) and the number of miscarriages 
(8,276) (Statistics Finland 2016b, 2017, 2019). Thus, a total of 63,612 toxoplasmosis 
tests are required. The cost of one test is €35. Therefore, the annual cost of toxo-
plasma testing would be €2.2 million (Table 9). The number of children has decreased 
in recent years, so it is expected that this cost will decrease over time. 
The test result may be one of the following: immunity, no immunity or infection. In the 
case of immunity, no further action is needed (about 20%) (Finnish Food Authority 
2019h). Those who are not immune to toxoplasma receive guidance on how to avoid 
infection. Therefore, the assumption is that no additional cost will arise. 
In the case of congenital infection, treatment is started before delivery. Further tests 
will likely be needed, but this cannot be assessed here. Pregnant women receive the 
same treatment as newborns for four weeks but at higher doses. The treatment is one 
tablet of pyrimethamine daily (two tablets on the first day of treatment) and six tablets 
of erythromycin daily. The cost of the medication is €192/patient, and the total cost is 
€3,263/year. We assume that one additional visit is required during week 13 of preg-
nancy. We also assume that this will not result in loss of productivity. The total cost is 
thus €5,000, which is probably an underestimate because it does not take additional 
tests into account. 
The additional cost in the scenario is €2.2 million, which will result in the disappear-
ance of congenital toxoplasmosis. 
A summary of the change from the current status to the scenario is presented in Table 
10. 
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Table 10. Summary of toxoplasma current status and scenario 
  Current status Scenario Difference 
DALYs 460 340 -120 
Costs (thousand €) 11,994 14,196 2,202 
  ACER 18,346.22 €/DALY 
 
3.4 Trichinellae 
3.4.1 Health effects 
Trichinella parasites (trichina) are small nematodes. Adult parasites are intestinal par-
asites whose larval forms live and become infectious in the muscles of the same host 
animal. Trichinella-associated disease is called trichinellosis. Infection can occur after 
eating meat containing infectious encapsulated trichinella larvae. The larvae capsules 
dissolve in the stomach and the released larvae develop into adult trichinae. Adult 
forms mate in the small intestine, and then females produce larvae that pass through 
the intestinal wall. The larvae migrate to the striated muscles and encapsulate there. 
The new host animal gets infected after eating meat containing Trichinella larvae (Hi-
dron et al. 2010). There are several species of trichinella (Foreyt 2013). Four of them 
are found in Finland, all of which can cause trichinellosis in humans. The most promi-
nent species is T. spiralis, whose most important host animals are pigs. The most 
common species in Finnish wildlife is T. nativa, which is adapted to arctic conditions 
and is highly resistant to freezing (Hallanvuo & Johansson 2010). 
In most cases, the symptoms trichinellosis in humans are mild to moderate; in severe 
cases (5%–10%), the symptoms and complications are prolonged and severe. In se-
vere cases, the symptoms (muscle pain, eye symptoms, neuropathies) can last up to 
10 years after the underlying disease has healed. The different stages of the para-
site’s life cycle cause different symptoms. In the first stage, the parasites released in 
the small intestine cause diarrhoea and abdominal pain, which can last 1–7 days. 
Gastrointestinal symptoms appear 5–15 days after infection. In the following week 
(Phase 2), larval invasion may cause fever, puffiness of the eyes and face, conjuncti-
val haemorrhage, headache, cough, shortness of breath, difficulty swallowing and 
sometimes a spotty skin rash. Migration of the larvae in the muscles causes severe 
pain, swelling, weakness and sometimes paralysis. In severe cases, there may be en-
cephalitis, cardiac dysfunction, miscarriage, central nervous system symptoms and 
death. In the third stage, larval encapsulation begins, with symptoms such as desicca-
tion, swelling, extreme dehydration and cardiovascular complications and in severe 
cases pleural, gastric and intestinal bleeding. In life-threatening cases, the patient 
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dies during the weeks 4–8 (Clausen et al. 1996). Muscle rigidity symptoms typical of 
stage three can persist for years after infection. Symptoms due to the migration of lar-
vae may recur after many years (Harms et al. 1993). 
3.4.2 Prevalence in food and current status in Fin-
land 
Humans typically become infected after consuming raw or inadequately cooked pig 
meat, wild boar meat, bear meat or meat products made with the blood of those ani-
mals that contain trichinellae (Food Agency, 2019f). Pigs can be infected, for exam-
ple, by eating contaminated rat or food waste (Hallanvuo & Johansson 2010). In Fin-
land, trichinae have been found in wolverines, hawks, polecats, seals, lynx, bears, 
hoofed animals (e.g. horses), foxes, dogs, cats, eagles, minks, badgers, pine mar-
tens, owls, otters, pigs, raccoon dogs, wolves and wild boars (Anon. 2015–2017). Of 
the animals examined in 2010–2016, trichinella was found mainly in wild boars, seals 
and bears and once in a pig carcass. 
Found in pigs, T. spiralis has been classified as another reportable microbial finding in 
the Government Decree on Communicable Diseases. Therefore, clinical laboratories 
are required to report any finding. In 2014–2016, trichinellosis was not reported in hu-
mans in Finland. The last reported infection was from bear meat in the 1970s (Finnish 
Food Authority 2019f). Trichinellosis is more common in men than in women 
(Devleesschauwer, 2015). This is probably related to hunting and eating wild game 
(Murrell and Pozio, 2000). Those infected are usually adults (Devleesschauwer, 
2015). In other Western countries, trichinellosis is increasingly associated with travel-
ling (Foreyt, 2013). Pork consumption is high in Finland, but meat from other animal 
species that may contain trichinella is not eaten regularly (Helldán et al. 2013). 
3.4.3 Current burden of disease caused by Trichi-
nella 
The last case of trichinella in Finland was in the 1970s. Therefore, the burden of trichi-
nella was zero in 2014–2016. 
3.4.4 Costs related to surveillance and morbidity 
Trichinella testing during meat inspection is regulated by the so-called trichinella regu-
lation (EC) 2075/2005. Regulation (EC) 2015/1375 of the European Commission lays 
down rules for the sampling of carcasses susceptible to Trichinella. Meat in which 
Trichinella has been detected is not consumed but is rejected, although it is possible 
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to freeze the meat under certain conditions, according to the time-temperature guide-
lines given. Trichinella testing of pigs in the context of meat inspection may be de-
creased or eliminated if the pigs have been raised under officially approved controlled 
housing conditions. To date, there are only a few such pig farms in Finland, but there 
were none in the 2014–2016 survey period. However, the countries to which pork is 
exported from Finland require that the carcasses from which the meat originates be 
tested and found free of Trichinella. 
In Finland, all four species of Trichinella were detected in animals examined during 
meat inspections in 2010–2016. Trichinella was found in one pig carcass of the more 
than 15 million examined. No trichinae were detected in the 10,000+ horses tested. In 
contrast, the prevalence of trichinella was 0.3% in wild boar carcasses, nearly 1% in 
seal carcasses and more than 6% in bear carcasses. In farmed wild boar, trichinae 
was found almost as frequently as in wild boar (Finnish Food Authority, 2019f). During 
the same period, Trichinella was detected in approximately 30%–40% of the 5,000+ 
samples taken from wild animals other than those mentioned above. In predatory 
birds (hawks, owls, eagles), Trichinella was only found in about 3% of the samples 
(Evira 2012; 2012b; 2013b; 2014b; 2015; 2016; 2017b). Treatment costs for trichinel-
losis in the years studied were €0, as no cases occurred.  
Even though no cases of trichinosis have occurred in Finland since the 1970s, moni-
toring of the parasite must be carried out according to EU rules. Because the scenario 
focuses on pig carcasses only, the cost estimations will also. In accordance with EU 
regulations, the occurrence of Trichinella in slaughtered animals has to be monitored. 
This applies to pigs, horses, wild boars and other game animals meant for consump-
tion. It is unclear what proportion of the monitoring expenses indicated by companies 
and municipalities relates to pork (Commission Regulation (No. 2015/1375)). 
The costs are inferred using the number of pig carcasses tested and the testing price 
for Trichinella per carcass. In the period 2014–2016, on average 2.07 million pigs 
were slaughtered annually, and every pig carcass had to be tested for Trichinella 
(Luke 2019, 2017). Based on a survey of Finnish pig slaughterhouses, the Trichinella 
test costs are €2/pig, including labour costs for sampling and laboratory personnel. 
This price covers 99% of the pigs slaughtered in Finland. The average price for the re-
maining 1% is €17.67/pig. For other food-producing animal species tested for Trichi-
nella, the average cost is also €17.67/carcass. Additional costs would occur if Trichi-
nella is detected. However, the Trichinella incidence in pigs is very low. During the pe-
riod 2010–2016, only one pig was found to be infected with Trichinella. Therefore, 
there are no noteworthy costs due to non-approved carcasses and rejections.  
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In total, the monitoring costs are estimated at approximately €4.5 million. As no cases 
of trichinosis have been registered in recent years, no treatment costs or production 
losses due to infection need to be considered in the cost calculation. 
3.4.5 Scenario 
The aim in the Trichinella scenario was to reduce control costs. In the scenario, Trichi-
nella was monitored in all other edible animal species at the present level (in 2014–
2016 an average of 2,350 carcasses/year), but the pig carcasses are monitored only 
in export companies. In the calculations, this was assumed to mean a reduction by 
half in the analysis of pig carcasses (an average of 2,061,500 pig carcasses/year 
were examined in 2014–2016). 
The selected scenario was chosen for the following reasons. Finland tests slaugh-
tered pigs for Trichinella routinely, although it is rarely found in pigs. In 2010–2016, 
only one carcass of the 15,000,000+ pig carcasses examined tested positive for 
Trichinella. Human infections are also very rare, with the last registered case being in 
the 1970s. It was therefore assumed that the disease would not increase due to the 
discontinuation of surveillance and that the cost of surveys would be significantly re-
duced. As Trichinella surveys are considered important in the countries to which Fin-
land exports pork, the continuation of testing in export establishments would probably 
be profitable, and therefore the scenario does not completely give up on controls. 
3.4.6 Cost-effectiveness and impact of the scenario 
on burden of disease 
In line with the scenario, Trichinella testing would be reduced so that pigs would only 
be tested if the meat is meant for export. The health burden of Trichinella in Finland is 
less than 1 DALY/year, so there are no significant health benefits. The effects of the 
scenario are mainly economic. However, it is possible that the BoD caused by Trichi-
nella in Finland will increase. In the absence of testing, it is possible that the parasite 
is unknowingly transmitted to pigs and thus enters the consumption chain. 
The scenario calculations focus exclusively on companies, as it is not expected that 
the Trichinella infection incidence changes under the scenario. Overall, the scenario 
includes a drastic cost reduction. Based on the Finnish export statistics for the years 
2014–2016, roughly 356,400 carcasses were destined for export annually (Luke 
2019), which would be the number of tests in the future. This is a significant decrease 
from the current 2 million annual tests. The expected new cost would be €770,000. 
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The change from the current state to the state of the scenario is presented in Table 
11. 
Table 11. Summary of trichinella current status and scenario 
Trichinella 
  Current situation Scenario Change 
DALYs 0 0 0 
Costs (thousand €) 4,469 769 -3,700 
  ACER - €/DALY 
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4 Physical hazards 
Physical hazards are related to, for example, heat, light or concrete objects. The most 
common physical hazards associated with food safety are foreign objects entering the 
food. The most common foreign objects found in food are bone chips or rock frag-
ments, but this varies depending on the raw materials and the method of production 
(Evira 2009). Metal or glass pieces, wooden sticks, jewellery, pens, pins, shots, hair, 
plasters or even small animals can be found in food. Poorly purified or pre-treated raw 
materials may also contain foreign objects (ETL 2006). 
In principle, foodstuffs should contain no foreign matter. Foreign objects may be re-
moved by an acceptance inspection or a visual or mechanical inspection at the pro-
duction stage (ETL 2006). In final products, foreign matter findings are rare and al-
most invariably limited to a single product or batch of products. A few foreign matter 
defects leading to product recalls are found in Finland every year (Evira 2009). 
In addition to possible product recalls, foreign objects can cause cost companies in 
the form of claims and product spoilage. Controlling foreign objects is important for 
companies due to the risk of damaging their reputation. At present, risk management 
is mainly based on own-checks and the actions of the operators. If the own-check re-
quirement level would be reduced, however, companies are likely to continue the 
same level of control because the requirements for the level of own-check come from 
customers (consumers and other companies) and not so much from legislation. 
Physical hazards do not have a major public health significance in Finland and are not 
associated with a major BoD. For these reasons, foreign objects were not examined 
further in this project and no scenario was developed for them. 
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5 Chemical hazards: Examples, 
current status and scenarios 
This chapter discusses the examples of chemical food hazards explored in the RUORI 
project. For each hazard, its impact on consumer health, its prevalence in food, infor-
mation on the exposure (intake) and related morbidity of the population living in Fin-
land, the BoD associated with that hazard and the costs of surveillance and morbidity 
at present will be described. After presenting the current situation, the scenario stud-
ied in the project and its impact on disease burden and costs will be described. 
Unlike biological food hazards where the infectious dose does not necessarily depend 
on the size of the individual, chemical food hazards are often assigned toxicological 
limits in relation to body weight. 
Detailed assumptions and calculation codes used to calculate disease burden esti-
mates can be found on the Opasnet Web Workspace RUORI page at 
http://en.opasnet.org/Ruori. 
5.1 Aflatoxins 
5.1.1 Health effects 
Aflatoxins are toxins produced by moulds of the genus Aspergillus. Such moulds typi-
cally appear in a product batch as dot-like growths; therefore, the aflatoxin contamina-
tion is not evenly distributed in the batch. Aflatoxins have a variety of forms (conge-
ners), of which B1 is the most harmful. At present, the climate in Finland is not very 
favourable for the growth of aflatoxin-producing moulds, and therefore domestic prod-
ucts contain considerably fewer aflatoxins than, for example, those produced in (sub) 
tropical countries. An exception to this is aflatoxin M1, which is produced in animals 
through the use of feed contaminated with aflatoxin B1 and which is excreted in milk. 
Similarly, in humans, aflatoxin B1 transforms into M1 in the liver and may be excreted 
in breast milk. 
Aflatoxins are carcinogenic, genotoxic, mutagenic, teratogenic and hepatotoxic and 
are (in mouse tests) immune system suppressants. Aflatoxin B1 is the most muta-
genic and carcinogenic chemical known (Herman & Walker) and has been specifically 
linked to the increased risk of liver cancer at low doses (tens of nanograms/kg body-
weight/day). People with hepatitis are particularly sensitive to aflatoxins. In addition to 
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carcinogenicity, aflatoxins are more commonly toxic to the liver (hepatotoxic) and in 
mice have been shown to suppress the immune system and thus aggravate brain le-
sions that develop in toxoplasmosis (World Health Organization 2002). 
For aflatoxin B1, a BMDL01 value has been determined for the increased risk of liver 
cancer in humans—0.078 µg/kg body weight/day. BMDL01 is the lower confidence in-
terval for the dose at which the risk of liver cancer increases by 1% of the risk in the 
non-exposed population. In humans suffering from hepatitis, the BMDL01 value has 
been determined to be 0.070 µg/kg bw/day (EFSA 2018). In France, exposure to 12 
ng/kg bw/day of aflatoxin is estimated to increase the incidence of liver cancer by 1.5 
cases/million people/year (EFSA 2007). 
5.1.2 Prevalence in food and current status in Fin-
land 
In Finland, about one in five imported batches of foodstuff contain residues of aflatox-
ins (Evira 2013). Aflatoxins are often found in peanuts and tree nuts, maize, rice (par-
ticularly dark basmati rice), corn and soybean meal, other cereals and cereal prod-
ucts, spices, figs, dried fruits, some imported feeds and their ingredients (Evira 2013). 
Commission Regulation (EC) No. 1881/2006 and its supplementary regulations set 
maximum levels for aflatoxins in various foodstuffs. 
The storage and transport of foodstuffs other than milk may result in a significant in-
crease in aflatoxin levels under conditions favourable to the growth of moulds (i.e. 
warm and humid conditions). Pasteurization and other heating methods kill moulds 
and thus prevent growth/unacceptable aflatoxin levels. In addition, milling, extrusion 
and the like can mechanically lower aflatoxin levels. However, aflatoxins are very per-
sistent in various treatments, such as cooking, roasting, etc., and may therefore still 
be present in preparations such as roasted nuts or bakery products (Marin et al. 
2013). 
Finnish aflatoxin exposure due to the consumption of peanut products (EFSA CON-
TAM Panel 2018) is estimated to be 0.9–1.1 ng/kg bw/day on average for the working-
age population, and 95% of the working-age population has an exposure of up to 2.4–
3.2 ng/kg bw/day. The estimate is based on the food consumption data of the Findiet 
2012 study and the concentration of control samples collected from EU countries. Alt-
hough the estimate is only for exposure to peanuts and peanut products, the JECFA 
estimate based on less accurate consumption data (JECFA 2016) places the average 
exposure to aflatoxin B1 in all foodstuffs in Finland at 0.9 ng/kg bw/day. 
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5.1.3 Current burden of disease caused by aflatox-
ins 
WHO has estimated the BoD caused by aflatoxins worldwide and regionally (Gibb et 
al. 2015). In 2010, foodborne aflatoxin exposure was estimated to cause a loss of 
636,869 healthy life years, equivalent to 9 DALYs/100,000 person years. For Western 
European countries, the WHO estimate of healthy life years lost due to aflatoxins was 
0.5 DALYs/100,000 person years (95% confidence interval 0.3–0.8).  
In Finland, direct use of the WHO estimate would mean an average annual burden of 
27 DALYs for 5.4 million Finns. An updated calculation was made using the EFSA 
(EFSA 2018) estimate of the dietary aflatoxin exposure in Finland. EFSA only esti-
mated aflatoxin exposure from peanut products, but according to the Findiet 2012 
data these were consumed more often than most other nuts and in larger amounts 
than the tree nuts eaten slightly more frequently. An estimate based on peanut prod-
ucts alone thus underestimates the total intake of Finns, but up-to-date information on 
aflatoxin exposure from all sources is not available. However, the rough intake calcu-
lated from the peanut and tree nut aflatoxin content measured in Finland and the food 
intake indicators of the Findiet 2012 survey are in the same range as the EFSA esti-
mate of the intake of peanuts alone (Suomi, personal communication). Therefore, the 
underestimation of disease burden is probably not high. 
The calculation used an average exposure of 0.85–1.14 ng/kg bw/day (EFSA 2018; 
values LB and UB) for 25–64-year olds, whose age group comprised 2,835,089 peo-
ple in 2014, and the average incidence of liver cancer in 2011–2015 (Finnish Cancer 
Registry) of 115 cases in this age group. For 65–74-year olds, the corresponding data 
were 0.5–0.67 ng/kg bw/day, with 615,487 people in the age group and 161 cases of 
liver cancer. The prevalence of chronic hepatitis infection in Finland was assumed to 
be 0.5%. These data updated the WHO estimate of the BoD due to aflatoxins (Gibb et 
al. 2015).  
The WHO method based on the PAF calculation and the functions described below, 
which take into account the higher risk of liver cancer for hepatitis B-positive individu-
als, were used as the disease burden calculation method. 
𝑃𝑃𝐴𝐴𝐹𝐹𝑎𝑎 = (1 − 𝑠𝑠) × 𝐻𝐻𝐴𝐴𝐴𝐴𝑎𝑎− + 𝑠𝑠 × 𝐻𝐻𝐴𝐴𝐴𝐴𝑎𝑎+𝐻𝐻𝐴𝐴𝐴𝐴  (9) 
In the above equation, HCCa- = b * a for hepatitis B-negative individuals and HCCa+ 
= b * h * a for hepatitis B-positive individuals. 
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In equations, p = the prevalence of hepatitis B infection, HCC = total incidence of liver 
cancer, a = aflatoxin exposure, b = cancer potential factor of aflatoxin for hepatitis B-
negative individuals and h = relative risk of aflatoxin for hepatitis B-positive individuals 
compared with HPV-negative individuals. The values used by WHO are for 100,000 
individuals, b = 0.01 (CI 0.002-0.03) and b * h = 0.30 (0.005-0.50) (Liu et al. 2010; 
WHO 2015). In other words, hepatitis B increases the risk of liver cancer by approxi-
mately 30-fold. 
PAFs (Table 12) were determined from the above calculations, describing the per-
centage of liver cases caused by aflatoxin exposure. 
According to the IHME GBD Database (University of Washington 2019), the total BoD 
for liver cancer in 2014 was on average 2,499 DALYs (2018–3115) for 25–64-year 
olds and 2,745 DALYs (2,245–3,311) for 65–74-year olds. 
Table 12. Population attributable fractions for liver cancer in Finland 
Age group (years) PAF (lower limit of average 
exposure) 
PAF (upper limit of average ex-
posure) 
25–64 0.0024 0.0032 
65–74 0.0002 0.0003 
Based on the PAFs and the IHME GBD total hepatocellular carcinoma burden, the af-
latoxin-induced BoD in 2012 was calculated to be 9.6 DALYs (CI 2.6–28) in the 25–74 
age groups. 
5.1.4 Costs related to surveillance and morbidity 
In Finland, the Finnish Food Authority controls imports of products of animal origin 
and Customs supervises non-animal products, including third-country imports and to 
some extent products from the internal market. In terms of the internal market, the 
control authorities of other EU countries also control foodstuffs; therefore, Finland 
does not incur any costs for their operation. In many countries, producers also have 
self-control checks to remove mould fungi that produce aflatoxins or other toxins from 
the food chain, such as removing damaged or visibly contaminated raw materials at 
the farm or early stages of the chain. 
The Finnish Food Authority compiles annual sector reports on its own control results 
and reports submitted by other authorities (municipalities, ELY, AVI, Customs, Valvira, 
the Defense Forces) and reports annually to the European Commission on the 
achievement of the objectives set forth in the control plan, the controls performed, de-
fects and sanctions (Finnish Food Authority 2019f). The latest control plan report once 
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again demonstrated that national food chemical monitoring programmes were imple-
mented as planned in 2017 and that the presence of contaminants is low (Finnish 
Food Authority 2019). 
Aflatoxins were examined using official controls in 2014–2016 on over 500 imported 
foodstuffs (third-country imports or products on the internal market) each year. Ac-
cording to the control plan, 40 samples of feed were to be analysed annually, but the 
result exceeded the plan (slightly over 50/year). Both imported foodstuffs and feed-
ingstuffs are tested for aflatoxin B1 and, in most cases, either total aflatoxins or differ-
ent aflatoxin congeners separately. In addition, the Finnish Food Authority monitors 
aflatoxin levels in raw milk from both production facilities and consignments via the 
national contaminant control programme. In 2014–2016, approximately 410 milk sam-
ples were analysed for aflatoxin M1, and residues were detected in four samples. Af-
latoxin M1 findings in milk are rare and result in investigations to identify the farms of 
origin. 
According to the survey in this project, 1%–5% of working time/year was spent on af-
latoxin monitoring in municipalities. According to the answers, no abnormal food sam-
ples (e.g. above the maximum level) for aflatoxin were found in 2014–2016. Only one 
supervisory authority responding to the survey reported that it had targeted aflatoxin 
control measures in 2014–2016. 
According to the Cancer Registry, 167,024 new cancer cases were diagnosed in Fin-
land in 2013–2017, or an average of 33,400 cases/year. Of these, 2,584 cases of liver 
cancer occurred during the five-year period, representing an average of 517 new 
cases/year. Assuming that all cancers cost the same and using the total cost of 
€1082.8 million proposed by Neittaanmäki et al. (2017) for 2015, the total cost of all 
cases of liver cancer in 2015 would be approximately €16,800,000. Aflatoxin-induced 
hepatocellular carcinoma was estimated to occur at less than one case per year in the 
BoD calculations. 
Aflatoxins in food products come with economic costs of about €1.5 million/year. The 
costs consist of monitoring expenses incurred by Finnish Food Authority, customs, 
municipalities and companies, as well as health care costs and related productivity 
loss. 
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Table 13. Aflatoxin-related costs 
Aflatoxin current situation, costs (thousand €) 
  Labour  Sampling  Control  Total  
Finnish Food Authority and Customs       255 
Municipal Control Authorities 100  0.2  0.3 100 
Companies 537  520 36 1,093 
Health Care Costs       28 
Productivity Loss       4 
Total 637 520 37 1,481 
At about €260,000, the monitoring of aflatoxins represents the major part of all moni-
toring costs, which are incurred by Ruokavirasto and Finnish Customs. For the munic-
ipalities and companies, the situation is different, as aflatoxin controls come with rela-
tively low expenditures of approximately €100,000 and €1.1 million/year compared to 
the monitoring of other substances. Overall, the labour needed for aflatoxin controls is 
the most expensive part of the monitoring (Table 13). 
In terms of health effects, aflatoxins are most importantly associated with the develop-
ment of liver cancer. However, the causality between exposure to aflatoxins and the 
development of liver cancer is not very strong. In 2015, 33,000 cases of cancer (of all 
types) were registered in Finland, of which one case (when rounding upwards) could 
be considered liver cancer related to high aflatoxin exposure. The annual health treat-
ment costs of an average cancer patient are €28,358. Cancer-induced productivity 
losses are estimated at €4,455 annually. The rounded value of one aflatoxin-induced 
cancer case totals about €33,000 in health costs. It is worth pointing out that the ac-
tual aflatoxin-induced liver cancer incidence is less than one case, meaning that the 
costs are likely a slight overestimation because there may be years when there are no 
aflatoxin-induced cases.  
5.1.5 Scenario 
As a scenario to reduce the BoD caused by aflatoxins, a situation where control of im-
ported nuts is increased and thus consumer exposure is reduced was investigated. In-
creased controls would target batches of nuts that have had the highest aflatoxin con-
tent among the control samples in recent years—pistachios, almonds and peanuts. 
Ten percent more of these nut batches would be tested, and fewer aflatoxin-contami-
nated lots would enter the market. 
In samples taken over several years under official control, about 16% of pistachio 
samples, about 5% of peanut samples and about 1% of almond samples have ex-
ceeded the maximum level set in EC 1881/2006 for aflatoxin contamination. The cur-
rent exposure assessment was based solely on exposure to peanut products (EFSA 
2018). About 50 peanut products are sampled each year. The scenario was estimated 
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to reduce aflatoxin exposure in Finnish adults by 0%–5%, which would also reduce 
the BoD due to aflatoxins. 
5.1.6 Cost-effectiveness and impact of the scenario 
on burden of disease 
The disease burden reduction effect of the aflatoxin scenario was estimated to be only 
0.24 DALYs (95% confidence interval 0.007–0.86 DALYs). The reason for this is not 
only low levels of aflatoxins but particularly the high risk of liver cancer in hepatitis B 
patients only, the percentage of which in the population is very small. The proposed 
scenario is to carry out 10% more controls of imported nuts, which comes with addi-
tional costs but would also decrease health care expenditures. 
Table 14. Aflatoxin scenario-related costs 
Aflatoxin scenario, costs (thousand €) 
  Labour  Sampling Control  Total 
Finnish Food Authority and Customs    259 
Municipal Control Authorities 100 0.2 0.3 100 
Companies 537 520 36 1,093 
Health Care Costs    28 
Productivity Loss    4 
Total 637 520 37 1,485 
The controls would be conducted by the Finnish Customs and would amount to about 
eight extra nut samples taken annually. The costs for one control sample are €458.00 
when assuming that a maximum of three samples are extracted per batch. Eight extra 
controls come with an additional cost of €3,664.00, which is incurred by the Finnish 
Customs Authority and gives a new total of €258,854. The costs for other monitoring 
actors are not expected to change (Table 14). 
The scenario is based on the logic that additional controls correlate with less aflatoxin-
contaminated products entering the Finnish market. In 2016, the Finnish Customs Au-
thority found seven non-compliant batches (Evira 2017c). Under the scenario, it is ex-
pected that the number of products refused entry to the Finnish market could grow, 
even if only slightly.  
In addition to market entry refusals, aflatoxin contamination might result in recalls if 
contamination is discovered after placement on the market. It is not possible to esti-
mate these costs within the scope of this research. 
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According to the DALYs calculations, it is expected that the scenario will reduce the 
number of DALYs by about 0.24 from 9.6 DALYs to 9.36 DALYs. It is worth remem-
bering that the estimated change in the number of cancer cases is very low, as it was 
already rounded up to one/year. The health costs thus remain the same in the sce-
nario, and the only change would be additional sampling costs of €3,664 (Table 15).  
Table 15. Summary of aflatoxins current status and scenario 
Aflatoxins 
  Current Situation Scenario Change 
DALYs 9.60 9.40 -0.2 
Costs (thousand €) 1,481 1,485 4 
  ACER 18,320 €/DALY 
5.2 Dioxins 
5.2.1 Health effects 
Dioxins (PCDD/F) refer to chlorine-substituted dibenzo-p-dioxins and furans. Only 17 
of these compounds are of toxicological significance. Dioxins are formed, for example, 
in incomplete combustion and in certain industrial processes. The advancement of 
combustion and industrial processes over the past decades has reduced the for-
mation of dioxins and their release into the environment.  
Polychlorinated biphenyls (PCBs) have been used, for example, in electronic equip-
ment and as hydraulic fluids. Dioxin-like PCBs (dl-PCBs) are compounds with dioxin-
like properties and therefore are often assessed together with dioxins. PCBs are inter-
nationally banned by the Stockholm Convention but are persistent in the environment. 
Dioxins and dl-PCBs can enter the food chain from the environment. Their concentra-
tion in foodstuffs is usually given as WHO toxicity equivalents (WHO-TEQ), where 
each dioxin and dl-PCB in a product is multiplied by its specific WHO toxicity factor 
(WHO-TEF). The total concentration is the sum of these multiplications. For most 
toxic compounds, the TEF is one. For dioxins, the TEF values are in the range of 
0.0003–0.3, and for dl-PCBs the TEF values are in the range of 0.00003–0.1. Cur-
rently, the TEF values published in 2005 (WHO-TEQ 2005) (Van der Berg 2005) are 
used. 
Dioxins and dl-PCBs are fat-soluble compounds that tend to accumulate in food of an-
imal origin and through that in the human body. They interfere with the functioning of 
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the reproductive system, nervous system and immune system and increase the risk of 
developmental disorders because they affect hormone function. A population study of 
boys' serum dioxin levels at 8–9 years of age and their sperm count 10 years later 
found that sperm levels were reduced to almost half of the control at the lowest expo-
sure level. Based on these results, EFSA set the Dioxin Tolerable Weekly Exposure 
(TWI) at 2 pg (i.e. 2.0 x 10-12 g) TEQ/ kg bw/week (EFSA Panel on Contaminants in 
the Food Chain 2018). 
5.2.2 Prevalence in food and current status in Fin-
land 
The major source of human exposure to dioxins and dl-PCBs is via food, especially 
food of animal origin. The total intake of these compounds in EU countries decreased 
by 17%–79% between 2002–2004 and 2008–2010, depending on the Member State 
and population (EFSA 2012). According to EFSA's latest estimate (EFSA Panel on 
Contaminants in the Food Chain 2018), the average intake (UB) of dioxins and dl-
PCBs (29 compounds) in Finland was 1.8 pg TEQ/kg bw/day for children below 
school age and 0.97 and 1.09 pg TEQ/kg bw/day for 25-64-year-olds and 65-74-year-
olds, respectively. The estimates are based on concentration levels in the EU and on 
Finnish food consumption studies DIPP and Findiet 2012. According to Findiet 2012 
data, the combined mean intake of the 17 most toxic compounds for 25–64-year olds 
was 0.42 pg TEQ/kg bw/day. According to these estimates, even the mean intake is 
above the tolerable weekly exposure limit set by EFSA. Even though the levels of di-
oxins in foodstuffs have decreased, they are still found in foods that have been in-
creasingly consumed, such as imported cheeses. In promoting export, it is worth high-
lighting the low dioxin content of domestic cheeses. 
According to the latest national estimate (THL 2017a), up to 80% of the total intake of 
dioxins and PCBs in Finland comes from wild fish. In 2017, dioxin and dl-PCB levels 
in Baltic salmon had fallen to about half of 2002 levels but still exceeded the EU legal 
maximum levels (Evira 2017).The GOHERR project 
(http://en.opasnet.org/w/Goherr_assessment) used a survey to collect consumption 
data and determined that the dioxin exposure from Baltic fish in Finnish adults was 35 
pg TEQ/day (not /kg bw), while in 2009 it was 67 pg TEQ/day due to higher concen-
trations. This report uses the results of the GOHERR project as a basis for the BoD 
assessment. 
In the Contaminant Regulation ((EU) No. 1259/2011, (EC) No 1881/2006) Finland has 
been granted a derogation authorizing the sale of Baltic fish in Finland, even if their 
levels of dioxins and dl-PCBs are higher than the maximum levels laid down in the 
Regulation (6.5 pg/g fresh weight WHO-TEQ). Finland's argument has been based in 
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particular on public health, that is, that the benefits of eating fish outweigh the risks of 
dioxins. Sweden, however, has highlighted the risks of dioxins and is considering 
abolishing the derogation on the grounds that other fish are available. The derogation 
is conditional on providing consumers with guidelines for the safe use of fish from the 
Baltic Sea (available at https://www.ruokavirasto.fi/en/private-persons/information-on-
food/instructions-for-safe-use-of-foodstuffs/safe-use-of-foodstuffs/). It is also condi-
tional on the annual notification to the Commission of measures to advise on dietary 
recommendations or to ensure that products not compliant with the maximum levels 
are not marketed in other Member States. The derogation requires that the effective-
ness of these measures be demonstrated and that dioxin levels in fish from the Baltic 
Sea area are regularly monitored. The commercial use of fish from the Baltic Sea in 
Finland therefore requires additional controls. 
5.2.3 Current burden of disease caused by dioxins 
The WHO estimates (WHO 2015) that food dioxins cause an annual BoD of 1 
DALY/100,000 inhabitants in Europe (95% confidence interval 0–9 DALYs/100,000 in-
habitants). In Finland, this would mean an annual BoD of 55 DALYs (confidence inter-
val 0–495 DALYs/year). The WHO assessment of health responses included hypothy-
roidism due to pre- and post-pregnancy exposure and reduced male fertility. 
The GOHERR project carried out an updated assessment of the BoD from consump-
tion of Baltic Sea fish. The estimate was based on an estimate of exposure to dioxins 
and dl-PCBs based on consumption data from the project survey. This benefit-risk as-
sessment took into account the negative health effects of chemicals and the positive 
effects of vitamins and fatty acids. Negative health responses in the GOHERR as-
sessment included cancer, childhood tooth damage due to exposure during gestation 
and reduced male fertility. An evaluation of the benefits of fish included the intake of 
vitamin D, the cardiac benefits of omega-3 fatty acids and the positive effect on infant 
brain development. In addition, the study included the neurotoxicity risks of methyl-
mercury in children. 
It is estimated that Baltic Sea fish are responsible for most of the dioxin exposure from 
food. According to the GOHERR project, exposure to dioxin and dl-PCB via Baltic Sea 
fish (without benefits) caused a disease burden of about 40 DALYs in 2009, which de-
creased to 22 DALYs in 2018 due to reduced dioxin levels. 
5.2.4 Costs related to surveillance and morbidity 
Maximum levels have been established for dioxins in the EU Contaminants Regula-
tion (EC) No. 1881/2006 and its updated regulations. The maximum levels have been 
VALTIONEUVOSTON SELVITYS- JA TUTKIMUSTOIMINNAN JULKAISUSARJA 2019:X 
 
64 
 
 
set for a number of different food categories and are subject to controls both by official 
agencies (Food Authority, Customs laboratory, municipalities) and by producers and 
manufacturers themselves. 
In national monitoring in 2014–2016, over 70 samples each year were analysed to de-
termine the level of dioxins. According to the survey in this project, in 2014–2016 mu-
nicipalities spent 2%–10% of their working time/year on dioxin control, and food sam-
ples exceeding the maximum levels were found. Only one supervisory authority re-
sponding to the survey reported it employed measures to control for dioxins in 2014–
2016. 
The health effects of dioxins only become apparent years after exposure. Some of the 
adverse effects, such as impaired fertility, do not require acute medical care; there-
fore, the associated morbidity costs are difficult to determine.  
The incidence of dioxins in foodstuff is associated with economic costs of roughly 
€27.9 million annually. The costs result from monitoring dioxin levels in food and from 
research projects but do not include estimations of the costs resulting from health ef-
fects (Table 16). 
Table 16. Dioxin related costs 
Dioxins current situation, costs (thousand €) 
  Labour Sampling Control Total 
Finnish Food Authority and Customs       62 
Municipal Control Authorities 132 0.09 0.6 133 
Companies 483 1,733 25,479 96 
Health Care Costs       unknown  
Productivity Loss       unknown  
EU derogation       40 
Total 615 1,734 25,480 27,930 
Dioxins are monitored by the Finnish Food Authority and Customs, an activity that 
costs about €61,600 annually. Municipalities and companies monitor dioxins less fre-
quently; they are assessed by only about 18% of companies and 25% of municipali-
ties. The money spent on monitoring is approximately €132,700, with labour costs 
constituting the biggest part. The major part of the total cost stems from the activities 
carried out by companies. It is estimated that companies spend nearly €27.7 million 
on dioxin monitoring per year (Table 16). 
As a part of the reporting duty related to the dioxins derogation, Finland carries out a 
research project every five years, the budget of which is typically €200,000, leading to 
annual costs of €40,000.  
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Dioxins have multiple hazardous effects on human health, such as interfering with the 
functioning of the reproductive system, the nervous system and the immune system. 
Because it is difficult to show the effect of dioxins on these systems, at the moment it 
is not possible to determine health care costs of dioxin exposure.  
5.2.5 Scenario 
As a scenario aimed at reducing the burden of dioxin-induced disease, the situation 
where Finland waives its derogation to keep Baltic Sea fish on the domestic market 
was examined. In the scenario, the consumption of Baltic Sea fish is replaced by the 
consumption of an equivalent amount of domestic lake fish or farmed fish. This would 
reduce the dioxin exposure of Finns and the resulting BoD and would reduce the pro-
portion of the population that exceeds the tolerable weekly intake of dioxins. However, 
the health benefits of eating fish would be maintained as long as total fish consump-
tion was not reduced. The scenario assumes that the health benefits do not change 
by changing fish species, although herring contains more healthy fatty acids than 
many typical lake fish, such as pike or zander, and less healthy fatty acids than rain-
bow trout. 
The scenario was chosen for the following reasons. Fish in the Baltic Sea have high 
levels of dioxins compared to domestic lake fish or farmed fish, and maintaining the 
derogation requires Finland to regularly investigate the occurrence of dioxins in Baltic 
Sea fish and to investigate whether consumers are aware of the recommendations. 
The levels of dioxin in the feed of farmed fish are monitored, and thus the concentra-
tion of dioxins in the fish can be controlled. 
The scenario assumed that there would be alternative uses for Baltic Sea fish, for ex-
ample, as feed material, as already today the vast majority of herring goes for feed 
and not human consumption. However, the selling price of edible herring is considera-
bly higher, so economically this scenario is disadvantageous for fisherman because 
they will lose income. 
5.2.6 Cost-effectiveness and impact of the scenario 
on burden of disease 
The dioxin scenario was estimated to decrease the Finnish BoD by 12 DALYs annu-
ally (95% CI from decrease of 67 DALYs to 35 additional DALYs). The scenario envi-
sions that Finns stop consuming Baltic Sea fish altogether. The total costs are ex-
pected to remain the same, although the financial impact may be different for the dif-
ferent parties involved. These are excluded from the project.  
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Table 17. Dioxin scenario related costs 
Dioxin scenario, costs (thousand €) 
  Labour  Sampling  Control Total  
Finnish Food Authority and Customs       62 
Municipal Control Authorities 132 0.09 0.6 133 
Companies 483 1,733 25,479 27,696 
Health Care Costs       unknown  
Productivity Loss        unknown  
EU derogation       40 
Total 615 1,734 25,480 27,930 
On average, Finnish fishermen landed 149,500 tons of Baltic Sea fish/year during the 
period 2014–2016. Approximately 89% of the catch was Atlantic herring, 9% was Eu-
ropean sprat and the rest consisted of different species (European Union 2017). Since 
the 1980s, Luke (2016) has observed a decreasing trend in the consumption of her-
ring by Finnish final consumers. Currently, Finns consume only 10% of the herring 
they used to consume in the 1980s, namely 3.5–4 million kg/year of herring. This cor-
relates to barely 3% of the 133 million kg of herring caught annually in Finland. The 
majority of the Finnish Baltic Sea catch is used as feed, and export is also high—in 
the case of herring roughly 40% of the catch. In other words, a relatively small propor-
tion of the fish caught in the Baltic Sea is actually consumed in Finland.  
In terms of municipal authorities and companies, it is assumed that the scenario will 
not noticeably impact their monitoring costs because dioxin levels are not only moni-
tored in fish but also in meat and other products (Commission Regulation No. 
1881/2006). Additionally, the exported fish products will need to be monitored. The 
economic effects of increasing the consumption of lake fish are not taken into consid-
eration. 
The reporting and research costs related to the derogation are assumed to continue 
at an average €40,000/year. The derogation might not be necessary in the long run, 
but in the short run the costs will remain. The health care costs cannot be estimated 
at the moment.  
All known costs are expected to stay at a constant level (Table 17). The change from 
the current status to the scenario is presented in Table 18. 
Table 18. Summary of dioxins current status and scenario 
Dioxin  
  Current situation Scenario Change 
DALYs 37 25 -12 
Costs (thousand €) 27,930 27,930 0 
  ACER 0.00 €/DALY 
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5.3 Lead 
5.3.1 Health effects 
Lead (Pb) belongs to the heavy metal category. Its levels in agricultural products are 
affected by natural concentrations in soil and by human activity, such as lead deposi-
tion from industry, shooting ranges or other contaminated areas and the previous use 
of petrol containing lead. Environmental lead ends up in food via contaminated water 
and food raw materials. 
Lead exposure has been linked to a number of health effects, such as kidney dam-
age, miscarriages, nervous system symptoms and an increased risk of hypertension 
(EFSA 2010). In addition, lead exposure has been linked to developmental disorders 
of the central nervous system in children and thereby to a decline in IQ (Wani et al. 
2015; Flora et al. 2012). Most of the health effects have only been found to be signifi-
cant at higher levels of exposure than the average consumer: as a result of occupa-
tional exposure or at concentrations well above current environmental exposure. Ex-
posure to lead has declined significantly in recent decades, particularly because lead 
fuels are no longer used and lead-coated water pipes have largely been replaced with 
lead-free ones. The main dietary sources of lead exposure are foods that are often 
consumed in high doses, even if their lead levels are not very high. 
There is no threshold for the critical effects of lead that could be considered as a ref-
erence level for safe intake. EFSA has established benchmark dose levels (BMDLs) 
for the various health hazards. These are lower confidence intervals for the dose that 
increases the risk of adverse events by a percentage indicated by the subscript rela-
tive to the risk in the non-exposed population. For childhood developmental neurotoxi-
city, BMDL01 is 0.50 µg/kg bw/day, which corresponds to a blood lead level of 12 µg/l. 
This corresponds to a decrease in IQ of one point. For kidney toxicity (decreased fil-
tration efficiency of kidneys) the BMDL10 is 0.63 µg/kg bw/day (15 µg/l in blood), and 
the BMDL01 for a 1% increase in systolic blood pressure is 1.50 µg/kg bw/day (36 µg/l 
in blood) (EFSA 2010). 
5.3.2 Prevalence in food and current status in Fin-
land 
As lead is an element, it can be present in trace amounts in all foods. Elevated levels 
of lead can be found, for example, in spices, game meat and animal offal, molluscs, 
nutritional supplements and diet foods. To date, there are no legal maximum limits for 
these foodstuffs. 
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Figure 5. Sources of exposure from food and drinking water in Finland for 3-year-olds (Suomi et al. 2015), 
above, and working-age Finns according to the consumption data of Findiet 2012 (Suomi 2019), below. After 
2010, no lead results above the limit of quantification have been found in monitoring milk samples; there-
fore, the importance of milk as a source of lead has decreased in the 2010s. 
Figure 6 shows the sources of dietary lead exposure for Finnish children and adults. 
The dietary exposure to lead was assessed in Evira's/Finnish Food Authority’s pro-
jects based on national food consumption data (DIPP and Findiet 2012 surveys) and 
occurrence data mainly from samples measured in Finland. As a result of using na-
tional concentration data, the exposure is lower than in the estimates previously pub-
lished by EFSA. 
The median exposure of Finnish children aged 1, 3 and 6 is 0.58 µg/kg bw/day, 0.40 
µg/kg bw/day and 0.34 µg/kg bw/day, respectively (Suomi et al. 2015). For Finnish 
25–74-year olds, the average dietary exposure from foods and tap water is 0.2 µg/kg 
bw/day (Suomi 2019). 
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5.3.3 Current burden of disease caused by lead 
The health impact assessment used WHO guidelines (WHO 2003b), updated with the 
findings of Lanphear et al. (2005), on the reduction of IQ in children as a result of ex-
posure to lead. The WHO guidelines are currently being updated, and it is possible 
that thresholds for the health impact assessment of lead will be lowered. According to 
the WHO statement (WHO 2018b) and the EFSA assessment (EFSA 2010), there is 
no safe threshold for exposure. 
Among the health effects, we looked at the decline in childhood IQ (mild intellectual 
disability, IQ below 70) and the increased risk of hypertension in adults. According to 
the current WHO guidelines (WHO 2003b), these responses should be evaluated for 
blood lead levels above 50 µg/l. However, Lanphear et al. (2005) showed that a de-
cline in intelligence already occurs with blood lead concentrations of 24 µg/l. There-
fore, this threshold is used as the threshold value and the dose response is the unit 
risk for the decrease in intelligence (0.039 IQ points per each additional 1 µg/l of blood 
lead concentration). The BMDL01 for neurotoxicity (IQ decrease) as calculated by 
EFSA is 0.50 µg/kg rp /day, which corresponds to a blood lead level of 12 µg/l (EFSA 
2010). However, this value cannot be used as a limit of action for a health impact as-
sessment as such, although it is useful as a reference value for conventional chemical 
risk assessment. 
The exposure of Finnish children aged 1, 3 and 6 to lead in food and tap water (Suomi 
et al. 2015) corresponds to blood lead levels of 14 µg/l, 10 µg/l and 8 µg/l, respec-
tively. For adults aged 25–74 (Suomi 2019), the blood lead level is 4 µg/l. Adult expo-
sure was found to be so low that no increased risk of hypertension could be detected. 
More than 5% of 1-year-olds were exposed to dietary lead, leading to elevated blood 
lead levels above the cut-off value for decreased IQ. For these 3,000+ children, the 
mean blood lead concentration was 27 µg/l, which would lead to an average decrease 
of 0.2 points in each child. The calculated BoD due to the decline in intelligence in 
Finland would be 570 DALYs/year. According to the exposure assessment included in 
Evira's risk assessment (Suomi et al. 2015), none of the children aged 3 or 6 would 
exceed the cut-off value for decreased IQ. 
5.3.4 Costs related to surveillance and morbidity 
Maximum levels for lead have been set in EU Contaminants Regulation (EC) No. 
1881/2006 and its updated regulations. Maximum levels have been set for a number 
of different food categories and they are monitored by official controls (Food Authority, 
Customs Laboratory, municipalities) and by producers and manufacturers. Lead in do-
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mestic drinking water is also controlled, in accordance with the domestic water regula-
tion. The table in Annex II of the Drinking Water Regulation lists the minimum fre-
quency of regular monitoring for different water distribution areas. 
Lead analyses were carried out in 2014–2016 by the Finnish Food Authority and the 
Customs Laboratory on a total of 360 imported foodstuffs and 690 domestic samples 
related to national contaminant monitoring (including meat and offal from farmed ani-
mals). One of the municipal supervisors who responded to the survey reports that 2% 
of their working time/year is spent on lead monitoring. According to the survey, no ab-
normal food samples (i.e. exceeding maximum levels) were detected in 2014–2016, 
and only one control authority responding to the survey reports that control measures 
were taken for lead during these years. 
The health effects of lead typically occur years or decades after exposure. Some of 
the side effects, such as mental retardation, do not require acute medical care; there-
fore, the associated morbidity costs are difficult to determine.  
The estimated economic costs of lead in food products are nearly €31.8 million/year. 
The majority of these costs are related to monitoring activities in companies. Due to 
estimation difficulties, health care expenses and productivity losses are not included.  
Table 19. Lead related costs 
Lead current situation, costs (thousand €) 
  Labour Costs, 
€ 
Sampling Costs, 
€ 
Control Costs, 
€ 
Total Costs, 
€ 
Finnish Food Authority and 
Customs 
      41 
Municipal Control Authorities 51 0.7 0.3 52 
Companies 1,540 552 29 653 31,745 
Health Care Costs        unknown  
Productivity Loss        unknown  
Total 1,591 552 29,654 31,838 
Based on the data obtained from the survey, lead is assessed by approximately 20% 
of companies and 25% of municipalities. The lead monitoring costs for companies are 
approximately €31.7 million but are comparatively low for municipalities, which appear 
to spend only around €52,000 (Table 19). In the case of companies, the control costs 
constitute the biggest cost factor (90% of the total costs), while for the municipalities 
the labour costs are the most expensive aspect (98%).  
Lead exposure has been linked to a number of health effects, such as kidney dam-
age, miscarriages, nervous system symptoms and developmental disorders (Wani et 
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al. 2015; Flora et al. 2012). Similar to the case for dioxins, it is not possible to allocate 
these effects using the information currently available. Therefore, further research is 
needed. 
Overall, the cost estimation related to lead is approximately €31.8 million annually. 
This is most likely an underestimation, as factors such as health care costs and 
productivity losses are not included.  
5.3.5 Scenario 
As a scenario to reduce the BoD caused by lead, a situation was investigated 
whereby fetal exposure to lead is reduced by limiting the lead content in foods that are 
the major sources of exposure among women of childbearing age. By limiting the die-
tary exposure of this population, the fetal exposure to lead would also decrease. The 
scenario focuses on diet foods (meals and bars) and tea powders, out of which 100 
extra samples would be taken every year in Finland and ingredients in excess of a 
certain concentration would be removed. The scenario assumes that this would be 
achieved, for example, by the addition of new maximum levels in the Contaminants 
Regulation (EC) No. 1881/2006. This would also lead to control measures elsewhere 
in Europe and would not constitute an obstacle to the internal market. At present, 
there are no legal limits for diet foods (meals and bars) or tea powder. 
If the levels of lead in diet foods were not higher than the maximum levels allowed for 
cereal products in the Contaminants Regulation and the maximum levels for lead in 
tea powder were to be equal to the maximum levels allowed for wines, the lead expo-
sure of Finnish women of childbearing age would decrease 3.7% at age group mean 
level and approximately 51% for the highly exposed part of the population group (to a 
level of 0.45 µg/kg bw/day, which is less than the BMDL01 value for lead associated 
with IQ decreases). 
The scenario was chosen for the following reasons. The BoD calculated in the project 
was related to lead exposure in 1–3-year olds. The main source is industrial baby 
foods, due to their high consumption. However, these foods already have the strictest 
limits set by the EU Contaminants Regulation. In the concentration data used in the 
risk assessment (Suomi et al. 2015), the majority of the industrial baby food samples 
measured were below the analytical limit of determination, but due to repeated con-
sumption and the low body weight of toddlers, the low concentrations lead to relatively 
high exposure. It was not considered practical to influence the exposure of Finnish 
children to lead by tightening the quality standards of children's food from current lev-
els, as access to sufficiently high-quality raw materials could become a problem. Re-
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garding raw materials for baby foods, there are stringent quality standards for the lev-
els of many contaminants in food in addition to lead levels. Therefore, the scenario 
sought to limit lead exposure during the fetal stage. 
In the long term, lead levels in food can be reduced by continuing good agricultural 
practices affecting the heavy metal content in raw materials and possibly favouring 
those (cereal) cultivars with the lowest heavy metal accumulation, if their other char-
acteristics are suitable for the purpose. 
5.3.6 Cost-effectiveness and impact of the scenario 
Sensitivity testing was carried out to assess the BoD caused by lead, as many chil-
dren's lead levels are only slightly below the threshold of 24 µg/l. The value is not de-
termined based on toxicological criteria but because the Lanphear (2005) data did not 
contain sufficiently lower exposures. Because lead has no physiological function in 
the body, its hazardous effects may not have any threshold value. Sensitivity testing 
showed this to be a surprisingly important assumption: only 7% of children initially ex-
ceeded the threshold, but assuming an uncertain threshold of 0–24 µg/l, the hazard 
estimate multiplied from 30 DALYs to 1,100 DALYs/year. As a result, both options 
were included in the final results. The results should be updated when further studies 
provide additional illumination of the effects of low exposures. Currently, the estimated 
BoD is 570 DALYs/year (95% confidence interval 0–4,100). 
The lead scenario was estimated to reduce the BoD for Finns by 40 DALYs/year (95% 
confidence interval 0–210 DALYs). The magnitude of the effect is limited by the fact 
that only a relatively small part of the total exposure is targeted. 
Another important assumption regarding lead is the occurrence of health damage. 
The IHME Institute has published a handicap weighting factor for IQ below 70, 
whereby only a small percentage of the population is affected. However, in this as-
sessment, it was assumed that even small changes in IQ are harmful; that is, the 
health damage is to the entire exposed population. 
The EU Contaminants Regulation ((EC) No. 1881/2006) does not set a limit for lead in 
tea or diet foods. In the proposed scenario, these products would be subject to moni-
toring. 
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Table 20. Lead scenario-related costs 
Lead scenario, costs (thousand €) 
  Labour Sampling Control Total 
Finnish Food Authority and Customs       41 
Municipal Control Authorities 51 0.7 0.3 52  
Companies 1,540 577 29,653 31,770  
Health Care Costs and Productivity Loss        unknown  
Total 1,591 577 29,654 31,863 
The scenario means annually performing 100 additional laboratory analyses spread 
randomly over the respective production facilities in Finland. The maximum level of 
lead envisioned as admissible is 2 mg lead/kg of product. The threshold is adopted 
from cereals in the case of diet foods and from wine in the case of tea. The assump-
tion is that Regulation No. 1881/2006 is amended to include these maximum levels, 
which implies that the updated rules apply within the entire European Union market.  
The additional control costs are covered by the randomly selected companies. Based 
on information obtained from the Finnish Customs Authorities, sampling and analysis 
for lead costs €250/sample. It is assumed here that companies have roughly the same 
costs and that the price already includes labour costs. The total annual costs for addi-
tional controls therefore add up to €25,000/year. The underlying assumption for the 
extra controls is that more products exceeding the lead limits are found and that their 
consumption is prevented. In the case that products are found to exceed the allowed 
lead concentrations, the entire batch is not allowed onto the market. Such a rejection 
has economic costs. However, as previously mentioned, the costs associated with re-
jections and recalls cannot be assessed in this project.  
Regarding other monitoring actors, the scenario does not envision a change in their 
practices and therefore no other costs are considered. In addition, estimating the 
changed health care expenses under the scenario is not possible, given that the cur-
rent health care costs are unknown.  
In summary, the additional costs of the lead scenario are €25,000 and are borne by 
companies (Table 20).Table 21 shows the change from current status to the scenario.  
Table 21. Summary of lead current status and scenario 
Lead 
  Current Situation Scenario Change 
DALYs 570 530 -40 
Costs (thousand €) 31,838 31,863 25 
  ACER 625.00 €/DALY 
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6 Nutritional factors: Examples, 
current status and scenarios 
Chapter 6 is about the nutritional factors studied. For each factor, we describe its im-
pact on consumer health, its prevalence in foods, information on intakes in Finland 
and related morbidity, the BoD caused by the factor and the current costs of surveil-
lance and morbidity. After the presentation of the current situation, the burden and 
cost of the scenario and the impact factors studied in the project will be described. 
Detailed assumptions and calculation codes used in BoD assessment can be found 
on the Opasnet Web Workspace RUORI page at http://fi.opasnet.org/fi/Ruori. 
6.1 Underconsumption of fruits and 
vegetables 
6.1.1 Health effects 
Fruits and vegetables are rich in healthful nutrients, such as dietary fibre, vitamin C, 
carotenoids, folic acid, vitamin E, vitamin K, potassium and magnesium (Nordic Coun-
cil of Ministers 2018), and other bioactive substances the health effects of which are 
not fully known (National Nutrition Advisory Board 2014). In a follow-up study of more 
than 450,000 people, the consumption of fruits and vegetables was associated with a 
lower risk of death (Leenders et al. 2013). There is convincing evidence that fruits and 
vegetables are associated with a lower risk of cardiovascular disease (WHO 2003). In 
the meta-analysis, the lowest risk for cardiovascular disease and overall mortality was 
observed at more than 800 g/day of fruits and vegetables. A reduction in the risk of 
coronary heart disease, heart attack, heart disease, and cancer was observed for 
each additional 200 g/day of fruits and vegetables (Aune et al. 2017). 
There is also evidence that fruits and vegetables provide protection against gastroin-
testinal cancers and lung cancer (Nordic Council of Ministers 2014). The lowest risk 
for cancer was found when fruit and vegetable consumption was 550–600 g/day 
(Aune et al. 2017). The abundant use of fruits and vegetables also helps in weight 
management (Nordic Council of Ministers 2014). 
According to WHO, fruit and vegetable consumption should equal at least 400 g/day 
(about 5 servings a day) (WHO 2003), while the Finnish Nutrition Guidelines (VRN 
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2014) state that at least 500 g of roots, vegetables, berries and fruits should be con-
sumed each day (about 5–6 servings/day). 
6.1.2 Current situation in Finland 
According to Finravinto 2017 (Valsta et al. 2018), a Finnish study on the diet and nu-
trition of adults, on average men consumed 331 g and women consumed 402 g of 
vegetables (including legumes and nuts), fruits and berries a day. The corresponding 
figures in the Finravinto 2012 study (Helldán et al. 2013) were 380 g for men and 420 
g for women. The age categories in these surveys are slightly different. In 2012, the 
data was for those aged 25–64, and in 2017 the data was for those aged 18–74. Ac-
cording to Finravinto 2017, only 14% of Finnish men and 22% of Finnish women eat 
the recommended amounts of fruits and vegetables (Valsta et al. 2018). 
Preliminary data from the Natural Resources Institute's Nutrition Balance Sheet 2017 
(Luke 2017) show that Finns consumed an average of 65 kg of fruit and 64 kg of veg-
etables last year, a total of 353 g/day. Consumption figures for fruits and vegetables 
on the balance sheet are only indicative, as the amount of stock losses and other 
losses, for example, is not known. The nutrition balance is more about the amount 
available for consumption than actual consumption (Luke 2017). In addition, the fruits, 
berries and vegetables picked or cultivated themselves are missing from the nutrition 
balance figures. 
6.1.3 Current burden of disease due to low con-
sumption of fruits and vegetables 
GBD studies by the IHME Institute estimated that in the years 2014–2016, the low 
consumption of fruit caused a burden of 34,500–35,300 DALYs in Finland each year. 
Seventy-five percent of this burden was due to cardiovascular disease, with the re-
mainder being fairly evenly distributed between cancer, diabetes and kidney damage. 
The underconsumption of vegetables in 2014–2016 was estimated to have caused an 
annual burden of 27,100–27,800 DALYs in Finland, which was fully explained by car-
diovascular disease. The RUORI model allocated 36,000 (95% confidence interval 
19,000–53,000) DALYs/year for the underconsumption of fruit and 29,000 (95% confi-
dence interval 13,000–44,000) DALYs for the underconsumption of vegetables. 
6.1.4 Costs related to surveillance and morbidity 
The nutritional aspects of fruit and vegetables are not subject to regulatory control. 
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No direct information has been published on nutrition-related morbidity costs, but ac-
cording to the IHME Institute (University of Washington 2019), in 2016 the burden of 
cardiovascular disease in Finland was 730,452 DALYs, 7.3% of which was explained 
by low fruit and vegetable consumption. The total burden of diabetes and kidney dis-
ease in 2016 was 159,800 DALYs, 2.8% of which was due to the underconsumption 
of fruit. The total burden of tumours in 2016 was 137,218 DALYs, 3.9% of which was 
due to the underconsumption of fruit. 
In 2012, the cost of all cardiovascular diseases accounted for 4% of all sickness cash 
benefits paid by the Social Insurance Institution (KELA); in other words, circulatory 
diseases caused 13,000 sickness benefit periods, a total of 76,900 days 
(Neittaanmäki et al. 2017). According to the same source, there were a total of 21,769 
cases of myocardial infarction and coronary heart disease in Finland in 2012, and in 
2014 about 12,000 Finns died from coronary artery disease. Medicines for the treat-
ment of cardiovascular diseases are also expensive. 
The total cost of cancer in 2011 was estimated at about €750 million, of which the di-
rect costs were €623 million. The Ministry of Social Affairs and Health estimated that 
the total cost of cancer would increase to 1.08 billion euros in 2015 and will increase 
to 1.5 billion euros in 2020 when it is estimated that over 33,000 Finns will have can-
cer. Approximately 30% of the estimated total treatment costs in 2015 will come from 
inpatient care, 28% from outpatient care and 24% from medicines. According to data 
from the early 2010s, the cost of treating one cancer patient is approximately €30,000 
(Neittaanmäki et al. 2017). 
Eating fruits and vegetables has positive health effects. The following is an estimate 
of the health costs of increasing fruit and vegetable consumption. Other costs, such 
as control costs, are not taken into account as they may not have any health implica-
tions. 
Obesity and overweight are major and independent health risks. However, they are 
also linked to the idea that eating high levels of fruits and vegetables is a substitute for 
eating other, unhealthy foods, thus facilitating weight management. However, obesity 
and overweight were not considered in this project because obesity management is 
linked to diet and physical activity as a whole, and it would have been very difficult to 
distinguish any single scenario that could have been studied in the same way as other 
scenarios of this project. 
The health effects take into account the three major diseases caused by the under-
consumption of fruit and vegetables—cardiovascular disease, diabetes and tumours. 
The costs of these diseases are based studies by Neittaanmäki et al. (2017) and THL 
(2014b). The costs include treatment costs, drug costs and loss of productivity. The 
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loss in productivity was estimated at €168/working day lost. There was no information 
on kidney disease and tumours, which is why the following figures are underesti-
mated. A study from the University of Washington (2019) was used to estimate the 
proportion of fruit and vegetables. The costs were €9.7 million for cardiovascular dis-
ease, €360,000 for diabetes and €29.6 million for cancer. The total cost is €39.6 mil-
lion. 
6.1.5 Scenario 
To increase the consumption of fruit and vegetables, a situation where the value-
added tax (VAT) on fresh fruits and vegetables is eliminated was investigated. How-
ever, the scenario assumed that the same amount of money would still be spent on 
fruit and vegetables. That is, a price reduction would increase the amount of fruits and 
vegetables consumed, although this is likely to overestimate the impact. 
The scenario was chosen after concluding that the elimination of the VAT on fresh 
fruits and vegetables would allow the majority of the population to increase their fruit 
and vegetable consumption, regardless of their socio-economic status. According to 
the literature, reducing the price of fruits and vegetables is the most effective way to 
increase their consumption (Cobiac et al. 2010; Dallongeville et al. 2019). A report on 
the impact of health-based food taxation on citizens’ health status and health inequali-
ties (Kotakorpi et al. 2011) looked at the changes in consumption that would result 
from reducing the VAT on fruits and vegetables from 13% (currently 14%) to zero. 
Consumer prices for these products would then fall by around 11.5%. For the sake of 
simplicity, these calculations assumed that tax changes would be passed on in full to 
the price of fruits and vegetables (Kotakorpi et al. 2011).  
The scenario to remove the VAT from fruits and vegetables was dealt as one scenario 
since the change in VAT would be the same for both fruits and vegetables. Because 
the scenario does not propose removing the VAT only from fruits or only from vegeta-
bles, separate ACERs do not offer any added value. For this reason, a common 
ACER is calculated for fruits and vegetables. 
The increased consumption of fresh fruits and vegetables would have direct public 
health effects by reducing the burden of cardiovascular disease and various cancers. 
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6.1.6 Impact of the scenario on burden of disease 
and its cost effectiveness 
Eliminating the VAT on fruits and vegetables was most effective in all the scenarios 
examined. For fruits and berries, the effect was 3,300 DALYs (95% confidence inter-
val 160–7,700 DALYs, standard deviation 2.100), and for vegetables, pulses and nuts 
it was 2,100 DALYs (95% confidence interval 88–5 5 200 DALYs, standard deviation 
1.400). The reason for good impact of this scenario is that changes in the VAT affect 
the eating habits of the entire nation. 
The scenario proposes the complete abolition of the VAT of 14% on fruits and vegeta-
bles. This would affect government tax revenues, household disposable income and 
corporate profits. 
Table 22. Costs related to eliminating the VAT on fruits and vegetables 
  Current situation /thousand €) Scenario (thousand €) 
Finnish Food Authority and Customs - - 
Municipal Control Authorities - - 
Companies - - 
Health Care Costs (including 
productivity losses) 
39,635 33,800 
  Cardiovascular Diseases  9,714 8,284 
  Diabetes 359 306 
  Tumours 29,562 25,210 
Forgone tax income (state)  - 310,065 
Additional Household Net Income  - 191,133 
  Additional Income - - 310,065 
  Additional Spending - 118,932 
Total Costs 39,635 152,732 
There are a number of financial implications of removing the VAT. The state loses tax 
revenue, and households save the same amount and allocate part of this money to 
buying fruits and vegetables. In 2014–2016, households spent €950 on fruits and veg-
etables (Statistics Finland 2019b). Thus, total expenditure on fruits and vegetables in 
Finland (about 2.66 million households, Statistics Finland 2019b) was €2.5 billion/year 
(including taxes). The VAT accounts for €310 million of the total expenditure. 
According to Kotakorpi et al. (2011), the change in demand resulting from eliminating 
the VAT on fruits and vegetables would be 5.37%. As a result, the additional expendi-
ture of households on fruits and vegetables is €119 million. This saves €191 million 
for other uses. This would also result in increased revenues for companies, but this is 
not considered. The increased consumption of fruits and vegetables would reduce 
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DALYs by 14.7%. Correspondingly, health care costs would be reduced by €5.8 mil-
lion (Table 22). 
The total cost of the scenario would be €152.7 million compared to the current state 
(€39.6 million); however, the DALYs would also fall. Overall, this scenario would result 
in an additional cost of €113.1 million. 
A summary is presented in Table 23. 
Table 23. Summary of the underconsumption of fruits and vegetables current status and scenario 
Fruits and vegetables 
  Current Situation Scenario Change 
DALYs 65,000 59,600 -5,400 
Costs (thousand €) 39,635 152,732 113,097 
  ACER 20,944 €/DALY 
6.2 Excessive intake of salt 
6.2.1 Health effects 
According to WHO, reducing salt intake is one of the most cost-effective ways to im-
prove population health. To that end, WHO has set a target of a 30% global reduction 
in average salt intake (WHO 2013). 
There is ample evidence of the hypertensive effect of excessive salt intake. Reducing 
salt intake lowers blood pressure with the highest effect to them with hypertension but 
is also detectable in people with normal blood pressure (WHO 2012). 
High salt intake increases the risk of stroke and has also been linked to other cardio-
vascular diseases (WHO 2012, Nordic Council of Ministers 2014, Jayedi et al. 2018). 
Due to its powerful hypertensive effect, it may increase overall mortality (WHO 2012). 
In addition, high salt intake has been found to be associated with gastric cancer (He & 
MacGregor 2010; D’Elia et al. 2014), osteoporosis and the worsening of asthma 
symptoms (He & MacGregor 2010). 
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6.2.2 Prevalence in food and current status in Fin-
land 
Table salt consists of sodium chloride. Sodium is naturally present in most foods and 
is also intentionally added. The salt content listed on food packaging includes both the 
salt added to the food and the sodium naturally present therein. The salt content is 
obtained by multiplying the total sodium content of the foodstuff by 2.5. 
The recommended salt intake for adults is 5 g/day, equivalent to 2 g of sodium. The 
recommended intake of salt for 2–10-year olds is up to 3–4 g/day. Adding salt is not 
recommended for infants (VRN 2014). 
Salt intake in Finland has declined in recent decades thanks to cooperation between 
different actors and legislators (VRN 2014), but according to Finravinto 2012 this de-
cline has ceased (Helldán et al. 2013). According to the most recent population sur-
vey (Valsta et al. 2018), there has been no change in Finn’s salt intake in recent 
years. Salt is still overused, and the recommended daily intake of 5 g/day is exceeded 
by 86% of women and 98% of men (Valsta et al. 2018). According to the Finravinto 
2017 study (Valsta et al. 2018), men received an average of 8.7 g/day and women 6.4 
g/day. The main sources of salt for Finns were meat, egg and cereal products (Valsta 
et al. 2018). 
6.2.3 The burden of disease due to excessive salt in-
take at present 
The IHME Institute estimates that in the 2014–2016 period, excessive salt intake in 
Finland caused an annual burden of 26,400–27,100 DALYs, which accounted for 
more than 90% of the burden of cardiovascular disease. In the RUORI model's esti-
mation, this result was scaled for current salt intake in Finland and the changes 
brought about by the Heart Symbol scenario. In the current state of the RUORI, the 
burden due to salt intake was 32,000 DALYs/year (95% confidence interval 7,800–
58,000 DALYs). 
6.2.4 Costs related to surveillance and morbidity 
Salt is not subject to regulatory controls except for ensuring that labelling is appropri-
ate.  
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According to studies by the IHME Institute, in 2016 the annual BoD for all cardiovas-
cular diseases in Finland was 730,452 DALYs. Of these, 3.4% were linked to salt in-
take, particularly coronary heart disease, stroke and cancer. The total burden of dia-
betes and kidney disease in 2016 was 159,800 DALYs, of which 0.5% was due to ex-
cessive salt intake. The total burden of tumours in 2016 was 137,218 DALYs, of which 
1.3% were due to excess salt intake. The total cost of cardiovascular disease and 
cancer (Neittaanmäki et al. 2017) is presented above in connection with the costs of 
the underconsumption of fruits and vegetables. 
Excessive salt intake has adverse health effects. For this reason, EU Regulation 
1169/2011 requires the salt content of foodstuffs be declared. The costs arise mainly 
from controlling salt intake and the effects of its overuse. 
Although there are no actual upper limits for salt levels, there are different labels, such 
as the statutory High Salinity Label or the Heart Symbol, to help consumers choose 
products (WHO 2013). The cost of controlling municipalities and companies varied 
greatly. The cost of controlling companies ranged from €0–€400,000. The reason for 
controlling salt content may be different from that for controlling other harmful sub-
stances. Food businesses can modify the flavour, composition or shelf life of their 
products by adding salt. For this reason, the cost of monitoring companies is not 
taken into account here. The same applies to municipalities and other authorities. 
The health effects take into account the three major diseases caused by excessive 
salt intake—cardiovascular disease, diabetes and tumours. The costs of these dis-
eases are based on studies by Neittaanmäki et al. (2017) and THL (2014b) and in-
clude treatment costs, drug costs and loss of productivity. Productivity losses were es-
timated at €168/one lost working day. No information was available on the costs of 
salt-related kidney disease and tumours, which is why the following figures are under-
estimates. The IHME study of the University of Washington (2019) was used to esti-
mate salt content. The costs were €4.5 million for cardiovascular disease, €64,000 for 
diabetes and €9.9 million for cancer. The total cost was €14.4 million. 
6.2.5 Scenario 
The scenario to reduce salt intake was to investigate a situation where staff restau-
rants would only offer lunches that meet the Heart Symbol requirements. The sce-
nario was assumed to target the working-age population eating in staff restaurants. 
According to the Taloustutkimus (2010), around 63 million meals were prepared in 
staff restaurants in 2009, which corresponds to catering to some 279,000 employees 
on each working day of the year. Of those who had access to a staff restaurant, about 
half (35% of women and 30% of men) used it (Raulio 2011). 
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The project compared the nutrient content of a typical six-week menu at a staff restau-
rant and similar Heart Symbol-compliant meals. The information came from a large 
food service company. Averages of salt were calculated for regular lunch and Heart 
Symbol lunch. Different types of meals according to main course (sauce, piece food, 
soup, casserole) were chosen randomly from the six-week menu for four different op-
tions each day. In the example calculations, bacon ham sauce was chosen to repre-
sent the sauce main course and ham sauce was chosen for the corresponding Heart 
Symbol lunch. Salmon patties were selected to represent the piece food, sausage 
soup represented the soup and meat-and-pasta casserole represented the casserole, 
and for each of them was selected a corresponding Heart Symbol meal. Potato, rice, 
pasta and other side dishes of the main meals were selected similarly.  
The average regular lunch had 3.2 g of salt and the Heart Symbol lunch had 2.4 g. At 
weekly levels, salt intake was estimated to decline 3.3–5.1 g by switching to lunches 
that meet the Heart Symbol requirements. The nutrient content of the meals also in-
cluded side dishes The estimate was compared with the calculations in the Heart As-
sociation Report (Finnish Heart Association 2016), which estimated the use of salt to 
decrease 4.2–5.2 g. However, the Heart Association did not take into account items 
such as spreads, drinks or salad dressings. Previously (Raulio et al. 2017), it was also 
shown that replacing conventional foods (raw materials were not included) with Heart 
Symbol-compliant foods would reduce salt intake by 10%. 
This scenario was chosen because switching from high-salt to low-salt meals would 
reduce the average salt intake of the population and thus reduce the burden of cardio-
vascular disease due to excessive salt intake. Today, 98% of men and 86% of women 
exceed their salt intake recommendations (Valsta et al. 2018). The realization of the 
scenario would lead the majority of the population to have the recommended salt in-
take. It has been estimated (Jula 2011) that decreasing salt consumption by 1 g every 
day would save on average €70 million/year in health care costs on the population 
level. Most salt comes from industrial foods and meals outside the home (VRN 2014), 
so the importance of workplace eating in relation to salt intake is important. 
6.2.6 Impact of the scenario on burden of disease 
and its cost effectiveness 
The Heart Symbol meals only affect about 5% of the population, that is, the working-
age population who eat at staff restaurants. However, Heart Symbol meals are quite 
effective in that population. Salt reduction was estimated to reduce the BoD by 440 
DALYs/year (95% CI 100–990 DALYs/year see table 26). 
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In the scenario, state-subsidized meals in staff restaurants will be limited to Heart 
Symbol-compliant meals. 
Table 24. Costs related to excessive salt intake 
  Current situation (thousand €) Scenario (thousand €) 
Finnish Food Authority and Customs - - 
Municipal Control Authorities - - 
Companies - - 
Health Care Costs (including 
productivity losses) 
14,442 14,244 
  Cardiovascular Diseases  4,524 4,462 
  Diabetes 64 63 
  Tumours 9,854 9,719 
Total 14,442 14,244 
Only short-term effects are considered. The number of people dining at staff restau-
rants is not expected to change, and the monitoring costs of the Heart Association will 
not increase. Heart Symbol meals would reduce DALYs by about 1.38% (0.3–3.1%), 
resulting in a reduction in health care costs of approximately €200,000 (Table 24). 
The new total cost is therefore €14.2 million, which, under the assumptions of the sce-
nario, is only health care costs. As a result, the BoD will decrease by 440 (97–990) 
DALYs. 
The assumptions are that staff restaurants will comply with the Heart Symbol criteria, 
that production costs will not change and that lunch prices will remain unchanged. 
The governmental expenses are not expected to increase due to the subsidized 
lunches. 
A summary is presented in Table 25. 
Table 25. Summary of excessive use of salt current status and scenario 
Salt 
  Current Situation Scenario Change 
DALYs 32000 31560 -440 
Costs (thousand €) 14,442 14,244 -199 
  ACER -451 €/DALY 
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6.3 Excessive intake of saturated and trans 
fats 
6.3.1 Health effects 
Dietary fats can be divided into soft (unsaturated) and hard (saturated) fats based on 
their physical properties and health effects (THL 2016). Saturated fats refer to fatty 
acids with only simple bonds between them. Trans fatty acids act in the body like sat-
urated fats (THL 2016). Saturated and trans fatty acids are also commonly referred to 
as hard fat (Helldán et al. 2013). 
Saturated fats increase total cholesterol and harmful LDL cholesterol. The most fa-
vourable effects on total cholesterol and LDL cholesterol were observed when satu-
rated fatty acids were replaced with polyunsaturated fatty acids (Mensink 2016; 
Schwab et al. 2014) or monounsaturated fatty acids (Schwab et al. 2014). 
Epidemiological research presents methodological challenges in studying the role of 
fatty acid intake in the development of later-life cardiovascular disease. For example, 
not all studies have found an association between saturated fat and disease re-
sponses (e.g. Souza et al. 2015, Zhu et al. 2019). In a recent review (Clifton & Keogh 
2017), reducing saturated fat intake or replacing saturated fats with carbohydrates re-
duced overall mortality, although no reduction in coronary heart disease or cardiovas-
cular events was demonstrated. Instead, replacing saturated fats with polyunsaturated 
fatty acids, monounsaturated fatty acids or good-quality carbohydrates reduced the 
incidence of coronary artery disease (Clifton & Keogh 2017). Previous clinical studies 
and a WHO 2003 study have also shown that replacing saturated fatty acids with pol-
yunsaturated fatty acids reduces the risk of coronary heart disease (Micha & Mozaf-
farian 2010). 
In addition, saturated fat intake may be associated with unfavourable changes in insu-
lin metabolism, which is a risk factor for type 2 diabetes. There are also preliminary 
indications about the adverse effects of saturated fat on blood pressure and the risk of 
ovarian cancer (Nordic Council of Ministers 2014). 
Trans fatty acids also increase LDL cholesterol and additionally reduce health-friendly 
HDL cholesterol (Nordic Council of Ministers 2014). Their intake has been found to be 
related to the risk of cardiovascular disease (Zhu et al. 2019), total mortality and cardi-
ovascular mortality (Souza et al. 2015). 
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6.3.2 Prevalence in food and current status in Fin-
land 
Saturated fat is obtained from meat and meat products, butter and blended spreads, 
cheese and liquid dairy products and vegetable fat spreads and oils (Helldán et al. 
2013). Some vegetable fats, such as coconut and palm fat, contain high levels of sat-
urated fat (Helldán et al. 2013). Trans fatty acids are obtained either directly from ani-
mal foods or from industrially cured fats. Trans fatty acids are also produced in rumi-
nant rumen by bacteria (Nishida et al. 2009), which is why trans fatty acids are natu-
rally found in food from ruminants. The main source in Finland is dairy products. An-
other source of trans fatty acids are industrially cured vegetable oils. However, today, 
instead of curing transesterification is commonly used, whereby no trans fatty acids 
are formed during the process. In Finland, the margarine industry shifted away from 
esterification in the 1990s, so the current soft plant margarines are not relevant for the 
intake of trans fatty acids (THL 2015). 
Among other things, food labels indicate the nutritional composition of a product 
(Evira 2018) and the saturated fat content. At present, only saturated fats are 
counted; the amount of trans fat is not reported (Evira 2014). Currently, trans fatty ac-
ids are not considered to be such a health hazard in Finland that their inclusion on la-
bels is justified (Evira 2018). In other EU countries, the intake of trans fats is higher 
than in Finland, so in the future there may be requirements for limiting or labelling 
trans fats at the EU level (Evira 2018). 
In the Finnish Nutrition Recommendations (VRN 2014), the recommended fat intake is 
25%–40% of total energy, of which less than 10% is saturated fat. Trans fatty acid in-
take should be as low as possible (Helldán et al. 2013) and should remain below 1% 
of total energy. 
According to the Findiet 2012 and 2017 studies, most of the saturated fat intake of 
working-age people in Finland comes from dairy products, meat dishes and dietary 
fats (Helldán et al. 2013, Valsta et al. 2018). Milk and butterfat and bovine fat contain 
3%–5% trans fatty acids, soft margarines contain 0%–1%, industrial fats contain 0%–
7% and deep-frying fats contain 0%–2% (THL 2014). According to both Findiet 2012 
and 2017, milk, fats and meat were the main sources of trans fatty acids in the diets of 
the Finnish working-age population (Helldán et al. 2013; Valsta et al. 2018). 
According to the Findiet 2017 study, the proportion of fats in the total energy intake of 
18–74-year olds was 37.7% for women and 38.7% for men (Valsta et al. 2018). Satu-
rated fatty acids accounted for 14% (28 g/day) of total energy for women and 15% (38 
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g/day) of total energy for men. According to the Findiet 2017 study, trans fatty acid in-
take was 0.4% of total energy. Finns’ trans fatty acid intake is very low, so it has no 
significance for health at the population level (THL 2014). Instead, according to the 
latest information, 95% of the population consumes too much saturated fatty acid 
(Valsta et al. 2018). 
6.3.3 The burden of disease due to excessive fat in-
take at present 
In Finland during 2014–2016, the excessive intake of trans fats was estimated to have 
caused a BoD of 2,300–2,400 DALYs due to cardiovascular diseases (University of 
Washington 2019). 
In 2016, Wang et al. published country-specific calculations on the health effects of 
saturated and trans fatty acids. The WHO ICD-10 classified coronary heart disease 
(CHD) was the health response in the calculations. The country-specific case-volume 
data used were from WHO data (WHO 2019). Fat intakes were based on country-spe-
cific data or, in their absence, on more extensive data from several countries. The 
dose responses (relative risk, RR) used in the calculations, with uncertainty, were 
based on published meta-analyses from European and American studies. Country-
specific estimates of the number of cases caused by fats were published as additional 
material, from which the Finnish material was taken. Fat-related CHD deaths were 
calculated using the population causality (PAF) method with the formula: 
𝑃𝑃𝐴𝐴𝐹𝐹𝑠𝑠 = ∫ 𝐴𝐴𝐴𝐴𝑠𝑠(𝑥𝑥)𝑃𝑃𝑠𝑠(𝑥𝑥)𝑖𝑖𝑥𝑥 − ∫ 𝐴𝐴𝐴𝐴𝑠𝑠(𝑥𝑥)𝑃𝑃′𝑠𝑠(𝑥𝑥)𝑖𝑖𝑥𝑥𝑚𝑚𝑥𝑥=0𝑚𝑚𝑥𝑥=0
∫ 𝐴𝐴𝐴𝐴𝑠𝑠(𝑥𝑥)𝑃𝑃𝑠𝑠(𝑥𝑥)𝑖𝑖𝑥𝑥𝑚𝑚𝑥𝑥=0  , (10) 
where PAFi is the proportion of the population by age, gender and country; x is the 
amount of fat from the diet; Pi (x) is the probability distribution of dietary fat content by 
age, sex and country; P0i (x) is the optimum amount of dietary fat by age and sex; 
RRi (x) is the age- and sex-specific multivariate adjusted mortality risk ratio of fat in-
take x relative to the optimal intake level; and m is the maximum intake of fat from the 
diet. The exact distributions used in the calculation are described in OpasNet at 
http://fi.opasnet.org/fi/Ruori. 
PAF from calculations of Wang et al. (2016) was updated with the consumption of sat-
urated fats found in the Findiet 2017 study (Valsta et al. 2018). The calculation was 
performed with a simple ratio assumption using the formula below, where E is the ex-
posure and E10 is the upper limit of the optimal exposure. 
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𝑃𝑃𝐴𝐴𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 = 𝑃𝑃𝐴𝐴𝐹𝐹𝑊𝑊𝑎𝑎𝐹𝐹𝑊𝑊 × (𝐴𝐴𝐹𝐹𝐹𝐹𝐹𝐹 − 𝐴𝐴10)𝐴𝐴𝑊𝑊𝑎𝑎𝐹𝐹𝑊𝑊 − 𝐴𝐴10  (11) 
The intake data of the Findiet 2017 study are slightly different in terms of age group-
ing than that in Wang et al. (2016), so data for the 25–69 age group were used for the 
25–64 age group and data for the 70+ age group were used for the 65–74 age group. 
In addition, Statistics Finland's Death Registry data on the number of deaths due to 
ischemic heart disease in 2012 were used (Table 26). 
Table 26. Updated data for saturated fat health effect calculations (average and 95% CI) 
  Intake (Findiet 2017) (%E2)) PAF; saturated fatty acids (intake 
>10%E) 
Age (years) IHD1) 
amount 
Average Lower li-
mit 
Upper li-
mit 
Average Lower li-
mit 
Upper li-
mit 
25–64 1 914 13.8 13.7 13.9 0.067 0.054 0.081 
70+ 9 185 12.9 12.7 13 0.047 0.033 0.061 
1) deaths from ischemic heart disease 
2) percent of energy intake. 
The IHME Institute’s GBD data provided the total BoD deaths due to ischemic heart 
disease in 2012. When combined with the population study of the Wang study (2016), 
the burden of saturated fat was calculated (Table 27). 
Table 27. Burden of disease from saturated fats (average and 95% CI) according to RUORI model 
 
Saturated fatty acids (intake >10 %E) 
Age (years) Average Lower limit Upper limit 
25–69 4,200 3,300 5,200 
70+ 4,900 3,400 6,500 
Total 9,200 7,400 11,000 
In Finland, the burden caused by saturated fat was estimated at 9,200 DALYs/year. 
This is clearly less than the major risk factors examined, that is, excessive salt intake 
and the underconsumption of fruits and vegetables. However, only BoD caused by is-
chemic heart diseases were considered for saturated fats, while for salt, fruits and 
vegetables DALYs had been possible to determine also for other diseases such as 
other cardiovascular diseases, tumours and diabetes. However, the issue is compli-
cated, as eating too much saturated fat can easily lead to overweight, which is an in-
dependent risk factor for BoD. Measures to reduce saturated fat intake might thus re-
duce overall energy intake and thus overweight, significantly increasing the impact at 
the same time. 
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6.3.4 Costs related to surveillance and morbidity 
Saturated fats and trans fats are not subject to regulatory controls except for ensuring 
that labelling is correct. 
According to studies by the IHME Institute in 2016, the burden of cardiovascular dis-
ease in Finland was 298,000 DALYs, of which 0.7% was attributed to trans fats. Trans 
fat intake was not estimated to have an effect on other health effects. The total cost of 
cardiovascular disease is presented in the context of the underconsumption of fruits 
and vegetables. 
Excessive fat intake is very similar to salt intake. For example, the same EU Regula-
tion 1169/2011 defines how companies should report the fat content of their food 
products, especially saturated fats. 
In terms of control costs, the situation is similar to that of salt. Legislation does not set 
limits for fat content; therefore, this review focuses on health care costs. Of the health 
effects, cardiovascular disease is the clearest effect, which is why this report focuses 
exclusively on it (WHO 2003; Uauy et al. 2009). The burden of excess saturated fat 
intake in this project, estimated at 9,200 DALYs/year, was 3% of the total cardiovas-
cular disease burden estimated by the IHME Institute (University of Washington 
2019a) in 2016. This gives us a cost of almost €400,000/year in health care costs. At 
present, it is not known whether excess saturated fat causes non-cardiovascular dis-
ease (Micha & Mozaffarian 2010; Schwab et al. 2014). 
6.3.5 Scenario 
To reduce the intake of saturated fat, the same scenario was studied as in the case of 
excessive salt intake, that is, replacing typical staff restaurant meals with Heart Sym-
bol meals. The project calculated an average of 12.9 g of saturated fat in the regular 
lunch and 5.4 g in the Heart Symbol lunch. On a weekly basis, saturated fat intake 
was estimated to decrease 22.0–58.1 g by switching to lunches meeting the Heart 
Symbol criteria. The other assumptions in the scenario were the same as in the salt 
scenario. 
The scenario was chosen for the following reasons. The shift from high saturated fat 
to low saturated fat meals reduces the average saturated fat intake of the population 
and the resulting burden of cardiovascular disease. At present, 95% of Finns con-
sume too much saturated fat (Valsta et al. 2018). A study published in 2017 (Raulio et 
al. 2017) showed that replacing regular foods with foods that meet the Heart Symbol 
criteria decreased the intake of saturated fat from the current 14 E% to below 10 E%, 
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the recommended level. Lunch meals are especially important because they are 
eaten by a large number of Finns and can serve as a model for other meals of the 
day, thus improving the quality of the diet and the nutritional habits of the population 
(STM 2010). By investing in mass catering, there would be a significant public health 
benefit. 
6.3.6 Impact of the scenario on burden of disease 
and its cost effectiveness 
Heart Symbol meals at staff restaurants affect only about 5% of the population, alt-
hough they are quite effective in that section of the population. Reducing saturated fat 
intake was estimated to reduce the BoD by 530 DALYs/year (95% confidence interval 
310–800 DALYs/year). The scenario is identical to the salt scenario. 
Table 28. Costs related to the excessive consumption of saturated fats and trans fats 
  Current situation (thousand €) Scenario (thousand €) 
Finnish Food Authority and Customs - - 
Municipal Control Authorities - - 
Companies - - 
Health Care Costs (including 
productivity losses) 
399 376 
  Cardiovascular Diseases 399 376 
Total 399 376 
 
The number of people dining at staff restaurants is not expected to change, and the 
ost of Finnish Heart Association supervision will not increase. The post-scenario 
DALY will be down 5.8% from the current 9,200 DALYs to 8,670 DALYs. This will also 
reduce health care costs by €23,000 (Table 28).The assumption is that staff restau-
rants will comply with the Heart Symbol criteria, that production costs will not change 
and that lunch prices will remain unchanged. The governmental costs of state-subsi-
dized lunches is not expected to increase. 
A summary of the change from the current state to the state of the scenario is pre-
sented in Table 29. 
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Table 29. Summary of excessive consumption of saturated fats and trans fats current status and 
scenario 
Saturated fats and trans fats 
  Current Situation Scenario Change 
DALYs 9,200 8,670 -530 
Costs (thousand €) 399 376 -23 
  ACER -43.39 €/DALY 
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7 Food safety requirements for 
export  
Food exports are important to Finland, and the goal is to double them to €3 billion by 
2025, according to Business Finland’s Food from Finland programme. The good repu-
tation and safety of Finnish food is the key to exports. In this project, the food safety 
requirements for exports were mapped by interviewing experts from the Export Team 
of the Finnish Food Authority. 
The importance of national contaminant control, microbiological control programmes 
and animal disease control in Finland’s food export industry was emphasized in the 
interview responds. The information requested by the countries Finland exports to in-
clude the content and implementation of the control plans regarding the previously 
mentioned fields and sometimes the results of the previous year’s control pro-
grammes. The target countries of export may also require that the maximum levels of 
contaminants permitted in Finland or the EU be compared with their own correspond-
ing limits. In addition, some target countries require the Central Authority (Finnish 
Food Authority) to carry out more frequent inspections of export establishments than 
is otherwise done. For example, in 2018, 20 control missions were conducted to verify 
that the requirements set for facilities nationally and by the exporting countries were 
met, and 22 audits were conducted to determine how well inspectors had realized the 
special characteristics of export. Each of these inspections lasted for at least one day 
and always involved at least two officials. 
In addition to surveys on contaminant control, the exporting countries sometimes 
come to the authorities with more specific inquiries about individual chemical food 
hazards, such as additives, and their approval process. If controlled substances are 
detected (in the analyses of the target country) or if the previous year's control results 
are not provided, the export permit for that food, the export permit for an individual es-
tablishment or the export of a specific food category (such as fishery products) may 
be compromised. 
It is essential to check for Listeria, Salmonella, Campylobacter and Trichinella when 
export-ing food and feedstuffs. Biological hazards also include all major and danger-
ous animal diseases, such as any World Organisation for Animal Health -listed animal 
diseases and other pathogens of interest to the target countries. The low prevalence 
of salmonella achieved through self-control and surveillance in Finland for decades is 
an important factor facilitating the export of food. Therefore, experts consider it im-
portant to check for salmonella when exporting food. It is also important to check for 
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many other zoonotic agents. For example, countries must consider the impact of Afri-
can swine fever on pork exports. Many countries require that Finland’s export permit 
for pork guarantees that Finland is free of African swine fever. This applies both to 
farmed pigs and to wild boar. Depending on the food, Listeria controls are of particular 
importance for Russian, Chinese and US exports; Listeria findings may result in plant-
specific export bans on goods to these countries. Some countries importing Finnish 
goods countries may also require that every pig carcass, at least for export, be exam-
ined for trichinae, and some countries require that the pigs for export originate from an 
area that has been free of trichinae for a certain period. In recent years, genetically 
modified organisms (GMOs) have also been featured prominently in Russian exports, 
for example. 
So far, there have been very few issues regarding drug-resistant microbes in export-
ing countries, although the situation worldwide has worsened significantly in the last 
10 years. In its response to microbiological control programmes, Finland also men-
tions the control of resistant microbes, even if not directly asked. 
Nutritional factors for food exports are not significant from an official point of view, but 
they may be of commercial importance. Countries importing Finnish goods countries 
are interested in the cleanliness and safety of food imported from Finland, but there is 
no discussion on nutrition at the official level. The exception is genetically modified 
products, but even in this case, exporting countries consider the safety aspect. It is 
the responsibility of export companies to determine the requirements of the destina-
tion country, for example, with regard to labelling. 
In conclusion, reducing the control of biological or chemical hazards for Finnish food 
exports could lead to the need for new export negotiations and further clarifications or, 
at worst, export bans. Therefore, the reduction of controls was examined as a sce-
nario only for trichinella but in a way that could meet current or future export condi-
tions. In other words, a situation where only slaughter pigs for export would be investi-
gated would not affect people's illness but would significantly reduce costs for compa-
nies. 
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8 Conclusions 
8.1 Main results 
The main objectives of the project were to identify the major health and economic 
risks related to food and nutrition in Finland (Objective I) and to classify them to pro-
vide information for risk management (Objective II). Another objective was to estimate 
the costs of treatment, prevention and control of foodborne diseases. According to the 
study, the biggest risks are related to nutritional factors. The results indicate that the 
increased consumption of fruits and vegetables and the reduction of salt and satu-
rated fat in the Finnish diet would increase the amount of healthy life years by tens of 
thousands of years and save millions of euros. 
Another objective (Objective III) was to identify the food safety requirements of ex-
ports. According to the study, the reduction of controls could lead to problems with ex-
port requirements. Finland's export destinations particularly monitor the control of bio-
logical and chemical hazards, and the absence or weakening of controls could, at 
worst, lead to export prohibitions. 
The project identified a number of research areas and information gaps (Objective IV), 
which are discussed in Chapter 8, sections 8.3 and 8.5. The most important require-
ments are more accurate and comprehensive registry data and cost information, as 
well as information on the incidence, concentration and dose response of different 
food hazards. More consumer research is needed in this area. 
For each of the exemplary factors causing health problems used in the project, calcu-
lations for the current status were conducted (Objective V). Proposals for progress on 
the examined health hazards were evaluated from a public health and cost perspec-
tive using scenarios (Objective VI). The most influential of these involved nutritional 
changes in the diet (Tables 30 and 31 and Figure 6). Table 30 summarizes the BoD 
and total cost of studied hazards in 2014-2016, as defined in the previous chapters. 
The impacts of the scenarios on BoD and costs are presented in Table 31. 
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Table 30. The annual burden of disease in Finland caused by the example factors and the current 
total costs caused by the exposure agents 
Agent Burden of disease 
(DALY in a year), av-
erage (95 % CI) 
Main source Total costs calculated 
in the project (million 
€) 
Listeria 670 (400–950) WHO, updated with the case 
data from the Finnish case 
registry 
5.9 
Norovirus 200 (73–430) WHO, updated with the case 
data from the Finnish case 
registry 
7.4 
Toxoplasma 460 (250–740) WHO, based on the 
incidence in Europe 
(acquired infection) 
12.0 
Trichinella 0 No cases in Finland after 
the 1970s 
4.5 
Physical hazards  not calculated - - 
Aflatoxins 9.6 (2.6–28) WHO, updated with Finnish 
exposure levels, cancer 
registry data and liver 
cancer burden of disease 
from IHME GBD 
1.5 
Dioxins 37 (4.8–110) GOHERR project 2.9 
Lead 570 (0–4,100) Calculated in the project 
from Lanphear 2005 and 
Finnish exposure data 
31.8 
Underconsumption of 
fruits 
36,000 (19,000–53,000) IHME GBD 39.6 
Underconsumption of 
vegetables 
29,000 (13,000–44,000) IHME GBD 
Excessive use of salt 32,000 (7,800–58,000) IHME GBD 14.4 
Excessive use of 
saturated fat 
9,200 (7,400–11,000) IHME GBD; Wang 2016 0.4 
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Figure 6. Disease burden in Finland of exposure agents assessed in RUORI project. The current estimate is 
shown with a blue bar, and the green bar shows the situation after the scenario to reduce the risk. It can 
take decades to develop a chronic disease, so the burden accumulates during several years; therefore, the 
impact of scenarios manifests slowly. This is unlike acute diseases that show immediate effects. There are 
several data sources, notably WHO and Washington University (for more details, see the text for each expo-
sure agent). 
Table 31. Change of burden of disease and costs in the scenarios shown for each exposure agent. 
The average cost-effectiveness ratio (ACER) is the total cost in relation to the total health benefits. 
Agent Change of burden of dis-
ease (DALYs/year), aver-
age (95% CI) 
Change in 
costs (million 
€) 
ACER 
(€/DALY/y) 
Increased fruit consumption -3 300 (-7700 … -160) + 113.101) 20,944 
Increased vegetable consumption -2 100 (-5200 … -88) 
Listeria -670 (-950 … -400) +1.03 >1,534 
Decreased intake of saturated fat -530 (-800 … -310) -0.02 -43 
Decreased intake of salt -440 (-990 … -97) -0.20 -451 
Toxoplasma -120 (-250 … -47) +2.20 18,346 
Lead -40 (-210 … 0) +0.03 625 
Norovirus -23 (-80 … -0.7) +21.35 928,209 
Dioxins -12 (-67 … +35) 0 - 
Aflatoxins -0.2 (-0.9 … -0.08) +0.004 18,320 
Trichinella 0 (0 … 0) -3.70 - 
1) The cost estimations refer to the combined fruit and vegetable scenario. To calculate the ACER value, the 
costs for the combined scenario and the sum of the DALY reductions were used. 
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8.2 Conclusions drawn from the results  
Food is a major contributor to the health of the population, both in terms of nutrition 
and food safety. In the RUORI project, the nutritional factors, especially the inade-
quate consumption of fruits and vegetables, had the greatest impact on the BoD of 
Finns. This underconsumption causes a loss of tens of thousands of DALYs each 
year because of cardiovascular disease and cancer, among other things. The exces-
sive intake of salt had the second greatest impact, affecting the health of Finns by the 
loss of tens of thousands of DALYs. The intake of saturated fat was also a major pub-
lic health problem. Of the biological food hazards, Listeria was the major contributor to 
public health, with a burden of about 700 DALYs, which was greater than the com-
bined BoD of norovirus, toxoplasma and trichinella. The annual BoD of the chemical 
hazards lead, aflatoxins and dioxins was approximately 600 DALYs in total, and the 
burden of lead was the largest of these three factors. 
There is no unambiguous formula for converting DALYs into costs. According to the 
literature, the cost of one DALY in the Western world is often estimated between 
€10,000 and €100,000. However, some practices for change have evolved. In the UK, 
for example, it is relatively easy to get approval for projects where the reduction of 
one DALY is achieved by investing less than €10,000, but investing more than 
€30,000 requires other significant justification. 
Food control costs are a major expense. A number of national and international regu-
lations, such as the so-called microbial criteria regulation and the contaminants regu-
lation, determine the acceptable criteria for foods. Compliance, for example, monitor-
ing to ensure concentrations are below the maximum levels, is monitored via compa-
nies’ own-check systems and via official control. Based on the project results, by im-
plementing the scenarios the best health benefits would result from an increase in fruit 
and vegetable consumption (€113 million), while increasing the supply of Heart Sym-
bol meals would save €220,000 in total costs. 
Due to the many years of own-checks by companies and official control, the BoD re-
lated to biological and chemical food safety in Finland is relatively low. If food controls 
were reduced to reduce costs, the situation could quickly deteriorate, as, for example, 
one additional Listeria case already corresponds to an increase in the BoD of 10 
DALYs. In addition to public health, reducing controls could hamper trade, particularly 
exports. 
Most of the costs of control fall upon companies. Therefore, the scenarios that affect 
mostly businesses also have the greatest financial impact. The dioxin and trichinella 
scenarios are the most economically efficient, as both DALYs and costs are reduced. 
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The norovirus scenario is the most ineffective, as a reduction of one DALY unit costs 
€1million. 
Currently, food control focuses mainly on managing biological, chemical and physical 
hazards. However, according to this study, nutritional factors are of major importance 
for public health, and further consideration should be given to ways of influencing 
them through legislative and other guiding methods. Guiding methods for nutrition 
have recently been reviewed in the ‘The Components of and the Steering Instruments 
for the Finnish Food Environment’ report (Erkkola et al. 2019). According to an exten-
sive literature review, most research evidence of non-economic guiding methods re-
lated to the effectiveness of standards and regulations, nutritional labelling and the 
combination of different guiding methods. Food choices can also be guided by finan-
cial aspects, such as taxes and subsidies. 
Food safety was found to be essential for Finnish food exports. Most attention in ex-
port negotiations and reporting on continued exports is paid to biological and chemical 
food hazards and their national control. Listeria, Salmonella, Campylobacter and por-
cine trichinae are the biological hazards of most concern in exporting, and the coun-
tries of export specifically want information on their prevalence and control. For chem-
ical food hazards, the target countries require information on the control of contami-
nants and on control results. In addition, the target countries may require more fre-
quent inspections of approved establishments. Reducing controls on biological and 
chemical food hazards could lead to export bans or the need to reopen export negoti-
ations. In contrast, nutritional factors are not essential in relation to exports. 
It should be noted that the scenarios did not address situations where the moderating 
of hygiene controls could lead to a dramatic increase in some pathogens. Conse-
quently, it cannot be directly deduced from the minor effects of the scenario whether 
exposure would be insignificant to public health in all circumstances. 
The BoD and the costs of the factors selected for the project were identified through 
scenarios that were considered most feasible by a joint workshop of companies, au-
thorities and researchers. In light of the project outcomes, the following results were 
obtained: 
• Abolition of VAT on fresh fruits and vegetables. It is estimated that 
an increase in fruit consumption as a result of the scenario would reduce 
Finns' BoD by 3,300 DALYs annually, and an increase in vegetable con-
sumption would reduce Finns' BoD by 2,100 DALYs. This scenario has 
an additional cost of €113 million due to tax loss and the ACER of ap-
proximately €21,000/DALY. 
VALTIONEUVOSTON SELVITYS- JA TUTKIMUSTOIMINNAN JULKAISUSARJA 2019:X 
 
98 
 
 
• Replacing staff restaurant meals with Heart Symbol meals. It is esti-
mated that a reduction in saturated fat intake as a result of the scenario 
would reduce the BoD for Finns by 530 DALYs/year, and a decrease in 
salt intake would reduce the BoD for Finns by 440 DALYs/year. Only 
about 5% of Finns are affected by this scenario, but for them it has an 
effective health promoting effect. The scenario reduces costs by 
€222,000. 
• Reducing the number of Listeria infections through control 
measures. The scenario assumes that increasing sampling and reject-
ing all positive food samples would result in zero cases of listeriosis, 
which is a clear overestimation of the effectiveness of the measure. The 
impact of the scenario on the BoD of Finns would thus be no more than 
670 DALYs. The cost of the Listeria scenario is approximately €1 million 
and the ACER is theoretically at best €1,535/year of DALYs. 
• Reducing the number of norovirus infections by analysing surface 
samples. This scenario involves analysing samples from commercial 
kitchens and food premises manufacturing RTE foods during the period 
when most norovirus infections occur. It is estimated that the scenario 
would prevent up to 35% of norovirus infections, and the BoD for Finns 
would be reduced by 23 DALYs. The cost of the Norovirus scenario is 
€21.3 million, and the ACER is €930,000/DALY. 
• Testing pregnant women for toxoplasmosis. This would reduce the 
BoD by up to 120 DALYs by eliminating congenital cases of toxoplasmo-
sis. The additional costs would be €2.2 million, with an ACER of 
€18,346/DALY. 
• Limiting the control of Trichinella only to slaughterhouses export-
ing pigs. The number of carcasses to be tested was assumed to be the 
same as the number of pigs to be exported. The impact of the scenario 
on the Finnish BoD was estimated to be insignificant, but its cost would 
be reduced by €3.7 million. 
The results of the scenarios concerning the major causes of foodborne diseases in 
Finland are presented above. The Trichinella scenario is particularly interesting be-
cause of the savings of control costs. 
During the project, a number of information gaps were identified, the most significant 
of which are detailed in sections 8.3–8.5. The results provide preliminary guidance on 
what cost-effective measures could be taken to further investigate without compromis-
ing public health. The project did not comment on the extent to which or the order in 
which changes should be made. 
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Due to the lack of information, the project estimates are subject to uncertainty, and it 
is recommended they be refined through further national research. However, regard-
ing the BoD, some conclusions are solid and would not change much with further 
studies. For example, the nutritional factors have a large BoD, and the BoD for chemi-
cal factors, with the exception of lead, was small, especially when compared with the 
concern they typically provoke. 
8.3 Dearth of information 
The cost-effectiveness assessments of the project did not take into account the costs 
of the rejected products, as their share could not be estimated based on the infor-
mation available. 
A survey on the costs of official control and own-checks carried out in the project pro-
vided only a limited number of answers. For example, there were no answers from 
restaurants or grocery stores. Due to the lack of information, it was assumed that the 
food hazards in stores are indirectly controlled by an own-check system, avoiding 
cross-contamination, monitoring temperatures, etc., and that only surface hygiene 
samples to control general hygiene are collected in stores. In addition, it was as-
sumed that there are precise criteria for ensuring the safety of raw materials and food 
in the supply contracts and that there is no production of food at grocery stores. 
The cost of controlling domestic water was not included in the cost estimates. Accord-
ing to estimates by the Finnish Water Utilities Association, the total cost of domestic 
water control by authorities in 2018 was approximately €3 million (Riina Liikanen, per-
sonal communication), but the contributions of chemical and biological hazards to the 
total cost could not be determined. Of the chemical hazards studied, only lead has 
limits in the Domestic Water Regulation; aflatoxins and dioxins are not present in 
household water. 
The information collected via the survey derived from a variety of sources, and its cov-
erage has been correlated, for example, with the numbers from OIVA registers of first 
destinations and premises manufacturing RTE food. 
Only some of the morbidity costs associated with the scenarios were only available; 
therefore, assumptions had to be used in assessing cost effectiveness. Similarly, the 
BoD was partly based on assumptions and international estimates, as national data 
were not available. 
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8.4 Limitations and assumptions 
Assessments of the BoD involve methodological simplifications in order to compare 
different exposures and health responses together. For example, when calculating 
numbers of cases, it is not usually possible to know whether the reduction in life ex-
pectancy in the population is because some people lose several years or because 
many people lose a smaller number of years. Similarly, it is not clear how to calculate 
the BoD for diseases from which people would have fallen ill or died had they not died 
from another disease. In addition, a reduction in exposure leads to a reduction in the 
BoD and thus an increase in the burden of some other diseases due to population ag-
ing. The changes are therefore dynamic, and the various diseases interact with each 
other. 
Simplifications and assumptions about the behaviour of diseases are thus necessary. 
Therefore, the BoD should be considered a statistical indicator of the magnitude of the 
various factors. Calculated case numbers do not mean that a given exposure would 
kill an estimated number of people each year. Although we estimate the causal rela-
tionships considered to be real, due to the nature of the BoD we mean that the burden 
is attributable to a particular exposure, even when we speak of causation, because 
we do not know the true number of cases. Not all data were available for the years 
2014–2016. Depending on the factor, the project utilized data that is as close as pos-
sible to these years, for example, food consumption data for 2017 and exposure esti-
mates based on 2012 food consumption data. Estimates of BoD (DALYs) were deter-
mined using a variety of methods and data from different sources, possibly with vary-
ing degrees of accuracy in the absence of completely comparable data.  
The analysis of nutritional factors was based on the IHME GBD data, where the rec-
ommended limits for the consumption of fruits and vegetables and the limits on salt in-
take differ from the Finnish nutrition guidelines. Thus, the BoD caused by nutritional 
factors may be either overestimated or underestimated compared to the calculation of 
BoD in accordance with Finnish nutrition guidelines. In addition, IHME GBD results 
may overlap, resulting in a higher estimate of BoD. The BoD of biological food haz-
ards was mainly determined based on WHO calculations by adjusting the estimate for 
Europe according to case data from the Finnish Register of Infectious Diseases. 
Other assumptions in the burden of biological hazard calculations are thus based on 
international estimates, which may lead to either overestimation or underestimation. 
Biological factors are associated with underreporting, as only cases where a patient 
was referred to a doctor and was tested and the test results were reported are in-
cluded in the register. These may represent only a few percent of actual cases. For 
example, 94% of norovirus cases are internationally estimated to be unregistered 
(Tam et al. 2012), and in the subset of foodborne cases the underreporting is proba-
bly similar. Finnish data on the frequency of underreporting have not been studied. It 
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should also be noted that the BoD assessment for biological food hazards only takes 
into account acute diseases and that the burden of sequelae remains unknown. 
The aflatoxin BoD was determined based on WHO calculations by adjusting the esti-
mate based on data from the Finnish Cancer Registry and utilizing an international es-
timate of exposure due to the consumption of peanut products. The BoD for other 
chemical food hazards was determined based on national estimates. 
8.5 Further research requirements 
In the future, it would be important to conduct a broader study of the BoD due to food 
and nutrition and the costs associated with it, as this project was a pilot project that 
mapped the available information and identified the major informational gaps. For ex-
ample, there was a lack of national data about underreporting related to registers, 
which may differ significantly from international estimates due to different societal 
structures and practices. Therefore, it would be necessary to clarify the proportion of 
patients entering the registers in relation to all cases of the disease in question in Fin-
land. 
More accurate calculations would require comprehensive information on the preva-
lence and concentration of different health-related factors for different foods and cate-
gories of food at critical points in the food chain. The current data is typically based on 
conclusions based on very small number of measurements. However, there may have 
been a lot of measurements with background information, but these data are not 
available to researchers. The observation made in this report also suggests that own-
check samples are frequently taken and investigated but that large-scale use of the 
results is left to up to individual companies. Often, only the results with findings and 
not the ones where nothing was found are reported from analyses conducted in re-
search projects. Reporting all the analyses would provide information for setting the 
results in proportion. 
The authorities have made numerous recommendations on food safety and nutrition, 
but so far, no comprehensive study has been carried out in Finland on how aware 
consumers are of these recommendations, whether they are being followed and which 
methods would be most effective in reaching the various population groups. The 
Finns are not a cohesive group, so the survey should cover a wide range of popula-
tion groups to find, for example, the regional, economic and ethnic differences (possi-
bly influenced by language barriers) and to take them into account for improving com-
munication. Similarly, it should be studied how familiar different companies are with 
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legislation and the degree to which they comply with legislation and recommenda-
tions. There may also be demographic differences affecting product safety in the way 
different businesses work.  
Studies have often focused on the food chain from the farm to the shopping bag, but 
many of the biological and some chemical food hazards are significantly influenced by 
the consumer's behaviour at home beyond official control. The Finnish Food Author-
ity’s Risk Assessment Unit has developed a method for food consumption interviews 
that also explores the factors involved in the handling and storage of food at home 
and thus provides information relevant to risk assessment that goes beyond conven-
tional food interviews, such as the Finravinto studies. Applying the method to data col-
lection, particularly for risk groups such as the elderly or pregnant and breastfeeding 
women, would provide valuable insight into both public health promotion and targeting 
official controls, but the Authority's current budget does not allow this. Data collection 
would only be possible with separate funding. 
Factors influencing consumer eating habits, such as the impact of the environment, 
for example, by highlighting healthy choices and making them easy to choose, have 
been studied in Finland (Erkkola 2019). In this project, it was assumed that it is possi-
ble to influence consumer choice by lowering the price of fruits and vegetables by in-
tervening in taxation and by adjusting the nutritional content of subsidized lunches 
with limitations on salt and saturated fat. The terms of government-sponsored meals 
should also be looked at from a public health perspective, for example, with regard to 
the composition of school meals and by targeting lunch voucher subsidies only on 
healthy foods. 
In addition, it would be necessary to carry out a more detailed assessment of the 
costs of control and own-checks, which would include costs for operators, for exam-
ple, in terms of refurbishment and extra cleaning. Further research is also needed to 
identify the most cost-effective and efficient testing and risk-management methods. 
Methods to replace surveys should be developed. Whether targeted at businesses, 
authorities or individual citizens, they provide information that is otherwise unavaila-
ble. Unfortunately, fewer and fewer respondents respond to surveys. In addition, be-
sides willingness, the interviews require a lot of resources. Therefore, research tools 
are desperately needed in place of survey and interview studies. 
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8.6 Recommendations 
Food is associated with cultural perceptions and a great deal of emotion, and it is not 
easy to control the way it is prepared, served or eaten. Food is a matter of common 
concern to us, which is why there is a daily need for it to meet our physical and mental 
requirements. Deficiencies in food safety and nutrition are detrimental to public health, 
whether in the short or long term. Using example cases, this project aimed to study 
the causes and consequences of the health risks associated with food in Finland and 
to find appropriate risk management measures. The onset of foodborne health haz-
ards takes time, and so even the strongest efforts to control them at the population 
level will take years or decades. 
In the scenarios, the theoretical maximum for reduction of the BoD was calculated. 
Realistic estimates strongly depend on several factors, for which sufficiently accurate 
information was not available. The actual decrease may be only a fraction of what the 
project estimates; therefore, further studies are needed to refine the estimates. 
Based on the results of the project, several proposals for action are suggested, the 
most important of which are the following: 
• The risk assessment of the impact of the Finnish food system on public 
health needs to be deepened and expanded so that the various health 
hazards can be directly compared. 
• The costs of food control and nutrition-related health care should be fur-
ther evaluated and compared with the benefits (cost–benefit analysis). 
In particular, it should be determined what kind of food control is effec-
tive in preventing health hazards and what kind of control measures 
could be eliminated without adverse effects. 
• The nutritional factors addressed in the report pose a significant BoD, 
and attention should be paid to the associated remedies. The potential 
of legislation, taxation, communication and other means to promote 
health must be explored openly. At the same time, when planning 
changes, the means by which the effects of steering are measured and 
evaluated must be planned and financed. 
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8.7 International comparison and the value of 
control 
Figure 7 shows the BoD due to dietary risk factors (excluding malnutrition) on the one 
hand and hygienic risk factors (including handwashing, clean drinking water and sani-
tation) on the other. Thus, foodborne microbes are not specifically included, but the 
figure gives a reasonable estimate for microbial diseases for a comparison of coun-
tries. 
 
Figure 7. Burden of disease (DALY/100,000 person years) by country due to dietary and hygienic risk factors 
(Washington University, 2019c) 
Note that the scales are logarithmic and dietary risks show 10-fold differences but that 
hygienic risks may show more than thousand-fold differences between countries. Fin-
land is an average Western European country in terms of dietary risks but is among 
the world’s best in terms of hygienic risks. The numbers in Figure 7 can be compared 
with the results in this report by scaling them to the Finnish population, that is, by mul-
tiplying them be approximately 50. 
The global comparison shows that there is a lot to do to reduce dietary risks. Even if 
the BoD is reduced by half, we only approach levels where many countries already 
are, so the level should be achievable in theory. Of course, making cultural changes, 
including to food culture, is always challenging. 
In contrast, almost no country has reached a better situation in terms of hygienic risks 
than Finland. Therefore, the focus should be on issues that might deteriorate the cur-
rent good situation. For example, the salmonella risk in Finland is very low even when 
compared with close neighbours, and this situation should be maintained. However, 
even if our hygienic situation deteriorated to the average EU levels, the absolute BoD 
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would increase by only 500 DALY/year. A similar improvement should be easily 
achievable with dietary changes. 
In the RUORI project, it turned out to be difficult to find information about the impacts 
of food monitoring on hygiene. It would be important to be able to estimate the impact 
of changes in monitoring on disease burden. With hygiene, the interest is specifically 
in whether monitoring can be reduced without adverse health impacts. The monitoring 
is typically obligatory, and therefore no data or experiences emerge regarding alterna-
tive approaches. 
The situation can be improved in two different ways. First, the actions should be docu-
mented in cases where quality problems emerge. Data about rejected batches and 
other actions help to estimate what risks were avoided when a quality issue was iden-
tified, that is, what the value of monitoring was. Trichinella is an interesting, extreme 
case; because positive samples are never found, the monitoring has no impact on ac-
tions in practice, even if batches were rejected in a theoretical case of a contamina-
tion. Therefore, the value in contamination reduction is zero, and all benefit comes 
from maintaining a good reputation. Regarding other microbes, RUORI did not have 
similar information available, even if the food industry probably had it in their own files. 
Collaboration could make this data available for societal use. 
Second, experiments can be performed on one hand in the production chain (dioxin 
removal was tested in fish oil production, and it appeared so effective that concentra-
tion monitoring is no longer necessary) and on the other hand in identifying the most 
useful monitoring points (the preventive approach of hazard analysis and critical con-
trol points is still a good practice). 
The dietary situation is different. Food items can be produced by standardizing the 
health-related constituents to a healthy level. The dietary quality is predictable and is 
adjustable by the producer. Additional challenges are in influencing individuals’ be-
haviour in a way that results in an overall healthy diet. 
Also in this area, experiments could produce new additional value. Even the limited 
experiment about basic income produced important information about what aspects 
can be affected by basic income and what aspects cannot. Similarly, healthy food tax-
ation, sugar tax or Heart Symbol meals and their effectiveness and applicability 
should be studied using experiments. Successful approaches could then be scaled 
up. The food industry and retail market obviously make their own experiments and 
supposedly are well aware of how the sales of a product can be increased by good 
layout, pricing or packaging. However, the objectives are partly contradictory to public 
health. It is also difficult to see how these trade secrets could be made available to so-
ciety to promote health. 
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A summary conclusion can be made based on the country-wise comparison of dietary 
and hygienic risks. Monitoring is most valuable in situations where the quality of raw 
materials, processes and end products vary significantly. Then monitoring is an effec-
tive way to guide processes to be more healthy, for example, by rejecting contami-
nated batches. In poor hygienic conditions, the importance of hand washing is known 
without having to measure, and with high-quality processes there is little to reject. 
With dietary issues, the variation in quality is not in the products but rather in the 
choice of individuals to consume healthy or unhealthy products. There are probably 
large variations in the knowledge and perception of dietary risks as well. These should 
be studied and understood better to help design actions that improve public health. 
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